Wharton

MBA Program in Health Care Management

2020 RESUME BOOK Contents Program Description ...... 4 Curriculum ...... 5

Graduates ...... 6-29

Internship Sponsors...... 30-31 Health Care Program Mentors ...... 32-36

Administration ...... 37

Faculty ...... 38-39

Thank you for your interest in the Wharton MBA Program in Health Care Management. For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218

215.898.6861 email: [email protected]

For information on the Wharton Health Care Management Alumni Association, visit www.whartonhealthcare.org

For detailed information on the Health Care Management Department educational programs, visit http://mba.wharton.upenn.edu/healthcare 2020 Health Care Management

MBA Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740 . Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution . As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education . Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine . The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874 . The world’s first psychological clinic was opened at Penn in 1896 .

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management . Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education . In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education .

Today, the Wharton School has more than 480 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research . The 1,785 students in the master’s degree program may choose from among more than 200 courses and over 19 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual .

This brochure is provided to introduce you to the 2020 Wharton Health Care Management Program graduates .

We encourage you to consider these individuals for employment .

3 Program Description

The Graduate Program in Health Care Management The Leonard Davis Institute of Health Economics is a full-time 2-year MBA curriculum offered (LDI) is an interdisciplinary center for research by the Health Care Management Department of and education in the organization, financing, the Wharton School . The program, the principal and delivery of health care . Through LDI, University educational effort at the Leonard Davis Institute of Pennsylvania faculty and staff work together of Health Economics, is designed to provide on issues concerning health policy, health managerial and technical expertise to students insurance, managed care, hospitals, corporations, interested in the health care management field . pharmaceutical companies, and other health- By combining the skills of the Wharton disciplines related organizations . Established in 1967, the with sensitivity to the needs of health care providers Institute appropriately bears the name of the late and recipients, the Wharton MBA health care Leonard Davis, one of the foremost innovators in graduate can effectively manage the delivery private health insurance in the United States . He of health services and products at all levels . was the founder of Colonial Penn Group, Inc ., a company that has pioneered in insurance for older The Program has produced graduates who have Americans . Both Mr . Davis and Mrs . Sophie Davis chosen careers in hospitals and other medical were generous benefactors to the University of institutions, pharmaceutical, biotechnology and Pennsylvania, contributing basic support for the medical device companies, financial services, activities of the Leonard Davis Institute . entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government . Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations .

4 Curriculum The Wharton Management Core

All students are required to complete the Wharton Management International Programs: Core . The Wharton School’s core curriculum is designed to Global Modular Courses: Short full-credit courses in an intensive increase crossfunctional integration, extend global experience, workshop format in a country relevant to the topic . strengthen leadership training, and introduce new courses on key management issues . The core curriculum provides ground- Global Immersion Program (GIP): work in basic management disciplines: economics, A high-level survey of the economic, cultural, and geo-political finance, financial and cost accounting, management science, drivers behind regions integral to the global economy . Students managing people and organizational design, marketing, then experience it in-country . operations management, the governmental and legal environment of business, statistics, and strategy . The Health Care Major Courses and Electives: These courses promote an understanding of concepts, Fixed Core: institutions, and issues involved in the organization, • Leadership: Foundations of Teamwork and Leadership financing, and delivery of health services and products • Marketing: Marketing Management in the United States . Health care electives are selected • Microeconomics: Microeconomic Foundation consistent with individual career objectives and interests . • Economics: Advanced Topics in Managerial Economics • Statistics: Regression Analysis for Managers Required • Management Communication: Speaking and Writing • Health Services System • Health Care Field Application Project Flexible Core: Operations, Information, and Decisions Electives • Quality and Productivity • Comparative Health Care Systems • Business Analytics • E-Health: Business Models and Impact • Information Technology and Business Transformation • Financial Management of Health Institutions • Innovation • Healthcare Data & Analytics • Operations Strategy • Health Care Entrepreneurship • Health Care Reform and the Future of Marketing the American Health System • Dynamic Marketing Strategy • Health Care Services Delivery: • Strategic Marketing Simulations A Managerial Economic Approach • Managed Care and the Industrial Organization Communications of Health Care • Advanced Persuasive Speaking • Management & Economics of Pharmaceutical, • Communications Challenges for Entrepreneurs Biotechnology, & Medical Device Industries • Management and Strategy in Medical Devices Accounting and Technology • Financial Accounting • Management of Health Care for the Elderly • Accelerated Financial Accounting • Management of Health Care Service Businesses • Financial and Managerial Accounting • Managing Health Care Organizations • Private Sector Development in Global Corporate Finance Health Development • Corporate Finance • Advanced Study Project • Accelerated Corporate Finance • Introduction to Corporate Finance The Health Care Summer Internship The internship is a 3-month management experience that Macroeconomics provides the health care major an opportunity to work with • Macroeconomics a senior executive in an organization of particular interest to • Introduction to Macroeconomics the student .

Management MBA Electives • Managing the Established Enterprise Opportunities are available for the health care major to pursue • Managing the Emerging Enterprise a second concentration in fields such as entrepreneurship, marketing, finance, or operations, or to pursue specialized Legal Studies & Business Ethics knowledge in areas such as health care financing or within • Responsibility in Global Management specialized segments of the health care industry including • Responsibility in Business managed care organizations, hospitals, pharmaceutical and biotechnology companies, medical device companies, specialty services organizations, and long term care organizations . Graduate courses are available throughout the University .

5 Jenna R. Ackerman Prateek Agarwal Sophie K. Alpert [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Harvard University, Cambridge, MA Bowdoin College, Brunswick, ME B .A ., Summa Cum Laude, Economics, 2013 A .B ,. Summa Cum Laude, Molecular A .B ., Mathematics and Economics, 2013 and Cellular Biology, 2015 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M D. . Candidate, 2020

An opportunity to work for a mission- An opportunity to leverage my clinical An opportunity to develop innovative driven organization in a strategic role and business experience to design and digital health products and drive that advances care delivery models implement systems-level interventions improved health care outcomes and strengthens the payer-provider to improve the quality of health care relationship. while reducing costs. Johnson & Johnson, San Francisco, CA Partnerships and Corporate Development Walmart, Bentonville, AR McKinsey & Company, Philadelphia, PA Intern (Global Health Tech), Summer 2019 Health & Wellness Strategy Intern, Summer Associate, Summer 2019 Developed digital strategy and Summer 2019 Reviewed and optimized a pharmaceu- partnership recommendation for Structured overall approach to and led tical company’s R&D portfolio using medication adherence consisting of model development for site selection qualitative and quantitative metrics . an analysis of patient needs, business for Walmart Health, a new in-store Researched and pre-populated scoring case to develop an internal solution health and wellness service offering . criteria for R&D opportunities and and vendor assessment . Evaluated Streamlined disparate efforts on site facilitated client workshops to collect 100+ digital solutions to address selection process and enabled leadership data . Subsequently, analyzed this medication non-adherence across alignment on strategic goals . data and synthesized results into different sectors, including: DTC recommendations for the client . pharmacy, care coordination and The Chartis Group, Chicago, IL behavior modification apps . Created Consultant, 2018 Sanguis, Philadelphia, PA and implemented scoring framework Associate Consultant, 2016-2018 Co-Founder, Head of Marketing and prioritization for vendor selection Advised $1B+ U .S . health systems on & Management, 2016-Present based on patient needs for medication strategic and operational initiatives . Co-founded Sanguis, a medical device adherence for top J&J brands . Designed and implemented population start-up that empowers patients to health business unit to prepare top prevent life-threatening infections Collective Health, San Francisco, CA academic medical center for new with cost-effective, at-home neutrophil Senior Operations Specialist, 2015-2018 risk-based products . Created compre- count testing . Conducted market Led team of Operations Associates hensive accountable care strategy for analysis and developed the company’s in the creation of a new claims rural integrated delivery network . pricing, regulatory and reimbursement classification system . Built and operated Developed financial model that strategy to help win first place at the account management database and identified $6M in potential annual 2018 Penn Wharton Entrepreneurship collaborated with engineering team net revenue from improved access Startup Challenge and raise ~$100,000 to develop product requirements for across 3 ambulatory clinics in major to date . Collaborated with co-founders flexible spending accounts product . academic system . to submit U .S . Utility Patent and PCT Streamlined requirements and applications . protocols for reinsurance reporting Berkeley Research Group, Chicago, IL and reconstructed the reporting Consultant, 2016 University of Pennsylvania, Department method . Senior Associate, 2015 of Neurosurgery, Philadelphia, PA Associate, 2013-2014 Medical Student Researcher, 2015-Present Cowen and Company, San Francisco, CA Managed clinical analytics projects Completed several clinical, translational Investment Banking Analyst, 2013-2015 and designed data visualization tools and basic science research projects that Executed capital markets and M&A for multi-facility health systems to have resulted in more than 30 peer- transactions for life sciences and implement organizational change reviewed publications and 25 oral medical device clients . Constructed and realize cost savings, specifically in and poster presentations . accretion/dilution, discounted cash clinical variation, patient throughput, flow and initial public offering models service line optimization and human to facilitate investment banking resources . opportunities .

6 Daniel S. Astrachan Matthew S. Baker Sheyda [email protected] [email protected] Bautista-Saeyan Vanderbilt University, Nashville, TN Brown University, Providence, RI B .S ,. Human and Organizational B A. ., Magna Cum Laude, Economics, 2014 [email protected] Development, 2012 Brown University, Providence, RI A .B ., Health and Human Biology, 2014

An opportunity to identify operational An opportunity to drive change in An opportunity to lead operations and improvements and define the strategy the healthcare system by investing in strategy in a healthcare organization of healthcare organizations to improve and supporting innovative healthcare that aims to improve access to care service delivery. technology and services companies. while lowering costs.

UnitedHealthcare, Minneapolis, MN Cityblock Health, New York, NY DaVita, Denver, CO Strategic Initiatives Intern, Summer 2019 Summer Fellow, Summer 2019 Redwoods Associate, Summer 2019 Developed operational playbook out- Developed framework for evaluating Analyzed effectiveness of existing lining standard operating procedures and prioritizing new partnership operational strategy and management for 5 business units supporting launch opportunities, including relative processes of patient assessment and of Medicare & Retirement bundled weighting of key assessment criteria selection for home dialysis treatments . payment product . Identified product and sources for information . Performed Developed and launched training and performance and analytics gaps and analysis on unit economics of new onboarding plan improving effectiveness presented recommendations to senior business and provided recommenda- of patient educators . Implemented leaders who deployed two-person tions to senior leadership team for pipeline management tools to improve team to prioritize implementation contract negotiations . Spearheaded patient education pipeline, improving for upcoming product release date . initiative to create dashboard translating patient conversion rate . health plan partner contracts into VAL Health, New York, NY strategic operating implications . Gartner, Washington, DC Senior Manager of Strategic Analytics, Senior Analyst, 2016-2018 2017-2018 Apax Partners, New York, NY Analyst 2014-2016 Senior Strategic Account Manager, Private Equity Associate, 2016-2018 Spearheaded successful global launch 2015-2017 Conducted industry, financial and of new product from inception to Strategic Account Manager, 2014-2015 business diligence to evaluate health- commercial launch enabling sale of Led curation and submission of $1M care investments for $50B AUM global 150 units, creating $5M revenue government grant for development private equity firm . Developed invest- impact . Enabled CEO decision for new of new program offering . Identified ment theses, managed third-party product launches in 2017 by leading opportunity to reduce expenses of key advisors and presented analysis to two product explorations, conducting account by 40% without compromising investment committee . Supported 50+ market research interviews, creating program quality . Decreased program two portfolio companies (Acelity and concept plan and business case, facili- launch time by 90% by streamlining Ideal Protein) by performing business tating senior stakeholder checkpoints, internal and external program imple- analyses, leading strategic initiatives, leading sales force training, and mentation processes, which resulted attending board meetings, assisting supporting sales interactions . Invited to in the elimination of program errors . with refinancings and evaluating M&A join integration team post-acquisition targets . Executed platform acquisition to facilitate market analysis and advise Aon Hewitt, New York, NY of medical cost containment solutions executive team on product portfolio . Health and Benefits Analyst, 2012-2014 business (Kepro) . Directed mental and medical health claims financial analysis on behalf of Citigroup, New York, NY Department and Health and Human Investment Banking Analyst, 2014-2016 Services to support publication of Advised healthcare clients on M&A, medical payment legislation guidelines financing, and strategic alternatives published by the Department of by developing valuation analyses, Treasury . Authored and evaluated performing due diligence and preparing proposals to provide Fortune 500 offering memoranda . Successfully client health insurance coverage . completed 4 transactions .

7 Elisabeth G. Berger Joseph Hannah H. Bogardus [email protected] [email protected] Brown University, Providence, RI Laurence Blundo Bowdoin College, Brunswick, ME Sc .B ., Cum Laude, Biomedical Engineering, [email protected] B .A ., Cum Laude, Biochemistry, 2013 2014 Babson College, Wellesley, MA B S. ., Summa Cum Laude, Business Administration, 2013

An opportunity to build predictive An opportunity to build successful An opportunity to help bring break- software systems that improve healthcare technology companies through therapies to patients by leading quality of care for patients. through a private equity investing role. strategy and operations at a pharmaceu- tical or biotechnology organization. The One Health Company, Palo Alto, CA Watermark, New York, NY Product Marketing Intern, Summer/Fall 2019 Acting Head of Financial Planning & Analysis Pfizer Inc., New York, NY Prepared for series A fundraising by (“FP&A”), Summer 2019 Pharmaceutical Marketing Summer developing pitch deck, managing VC Responsible for leading the development, Associate, Summer 2019 funnel, and analyzing key metrics introduction, and roll-out of both Supported the Global Commercial including TAM, LTV and CAC . Created Redshift (Amazon Web Services) data team for a rare disease asset . Involved marketing content for B2B and B2C warehouse and Qlik dashboards . in strategic initiatives and tactical channels . Managed team of three data scientists activities to increase disease diagnosis to author computer script for performing and in ensuring optimal launch timing Maven Ventures, San Francisco, CA sales, marketing, and financial analyses . across markets as part of brand launch . Summer VC Associate, Summer 2019 Led cross-functional teams, managed Supported the deal process for consumer Technology Crossover Ventures (“TCV”), relationship with creative agency and software VC by performing due New York, NY presented launch timing recommenda- diligence and preparing investment Associate, Private Equity, 2015 – 2018 tions to commercial leadership . memos in 3 investment areas resulting Identified and sourced $50M+ in 2 successful deals . Developed investment opportunities across PricewaterhouseCoopers, Boston, MA startup onboarding kit and managed vertical software and services categories Experienced Associate, Pharmaceuticals and series A fundraising efforts of spanning 6,000+ companies . Performed Life Sciences Advisory, 2016-2018 portfolio company . market sizing work, customer and Advised pharmaceutical companies management references, product on R&D strategy and implemented Syapse, Inc., San Francisco, CA assessments, and customer cohort, systems to improve efficiency and Senior Product Manager, 2017-2018 unit economics, and in-depth financial effectiveness of R&D operations . Led a technical team of engineers, modeling to evaluate deal structures Led client workshops to determine data architects and designers to and returns . Provided portfolio approach for R&D process improve- deliver real-world evidence analytics support for Watermark, tastyworks, ment, conducted analysis and bench- ecosystem . Launched initial product HireVue, Payoneer, OneSource marking to support recommended with internal data science team and Virtual, and Avalara (NYSE: AVLR) . operating models and executed external large pharma customer . recommendations . Harris Williams & Co., Boston, MA Change Healthcare, Emeryville, CA Analyst, Investing Banking, 2013 – 2015 Health Advances, LLC, Boston, MA Senior Product Manager, 2016-2017 Authored sell-side M&A transaction Senior Analyst, Analyst, 2014-2016 Product Manager, 2014-2016 marketing and process materials, Developed commercialization Led 3 engineering teams and 2 junior developed financial models and analyses, strategies for new and existing products product managers to deliver data and facilitated multi-party due diligence . and services for pharmaceutical, bio- aggregation platform including Spearheaded creation of TMT Group’s technology and medical device clients . underlying architecture, data ontology, Quarterly Software Sector Review, Directed primary research with clinical, terminology normalization, HIPAA which was distributed to several regulatory, pricing and industry de-identification and data curation thousand TMT Group contacts for experts; led market assessments; capabilities . Invented and patented marketing purposes . made strategic recommendations tool for human-assisted curation of to maximize ROI for clients . duplicative records . Founded Workout Wednesday and Dessert Competition Boston Children’s Hospital, Boston, MA events . Research Assistant, 2013-2014 Executed research protocols, analyzed experimental results and contributed to two publications .

8 Shane R. Bouchard Frederic F. Andrew A. Bravo [email protected] [email protected] Harvard University, Cambridge, MA (Beau) Brace Williams College, Williamstown, MA A .B ., Magna Cum Laude, Chemistry, 2014 [email protected] B .A ., Cum Laude, Chemistry and Economics, A .M ., Chemistry, 2014 Cornell University, Ithaca, NY 2015 B S. ., with Honors, Industrial and Labor Relations, 2013

An opportunity to support innovative An opportunity to build and scale An opportunity to build solutions that biotechnology companies in translating leading healthcare businesses through maximize patient health by targeting science into transformative medicines a private equity investing role. areas of highest unmet need. through a business development, strategy or operations role. Post Capital Partners, New York, NY Eden Health, New York, NY MBA Intern, Summer 2019 MBA Intern – Business Development, Magenta Therapeutics, Cambridge, MA Evaluated investments in healthcare Summer 2019 Business & Corporate Development Intern, and technology-enabled services Created proprietary database of Summer 2019 businesses for a middle-market private 2,000+ employers to enable targeted Developed term sheets and contributed equity firm investing out of a $100M sales outreach in NY, Washington to presentations for strategic partnering fund . Spearheaded due diligence on D .C . and Chicago . Developed process discussions . Spearheaded execution 7 potential platform investments to create partnerships between Eden of business operations contracts . Led within a home- and community-based Health & employee benefits brokers, external consultancy in conducting care investment thesis . driving future sales opportunities . Led pricing and market access research internal sales operations improvement and integrated output into business Sheridan Capital Partners, Chicago, IL processes; reduced time required to case for lead clinical programs . Built Associate, Private Equity, 2015-2018 identify sales cohorts from 5 days to commercial readiness roadmap for Evaluated, executed and managed 15 minutes . Magenta; presented to full Executive leveraged buyout investments in Team and integrated into Board companies across the healthcare space Bain & Company, Boston, MA presentation . for a middle-market private equity Senior Associate Consultant, 2017-2018 fund with $450M of committed capital . Associate Consultant, 2015-2017 Clarion | A Life Sciences Consultancy, Served as interim head of FP&A for Associate Consultant Intern, 2014 Boston, MA distressed portfolio company, working Management consultant specializing Manager, 2018 on-site with 15-member executive in healthcare . Project highlights: (1) Consultant, 2016-2017 leadership team . Managed multiple Created strategic, value-based play- Associate Consultant, 2014-2015 due diligence streams for 2 practice book in key healthcare markets for Led multiple concurrent case teams, management platform investments, 17 national payor . (2) Evaluated global providing day-to-day leadership, add-on transactions and 1 distressed pharmaceutical portfolio to determine developing conceptual frameworks, recapitalization . Negotiated credit which products to introduce to coaching team members and acting documents, managed credit facility American and European markets . as primary client contact . Managed expansions and participated in Additional projects in private equity, projects generating >$1 1M. and devel- negotiation of transaction documents . pharmaceutical, medical technology, oped proposals securing >$400,000 in and retail sectors . revenue over final year at firm . Helped Lazard Frères & Co., New York, NY launch PatientLink initiative, connecting Analyst, Global Healthcare Group, 3Derm Systems, Boston, MA Clarion teams with patients impacted 2013-2015 Program Manager, 2017-2018 by clients’ medicines . Project high- Supported senior professionals in the Oversaw development of new business lights: (1) Managed team in assessing sourcing and execution of mergers and opportunities and alternative revenue in-licensing opportunities for mid-cap acquisitions mandates for large-cap streams, reporting to CEO . Managed specialty pharmaceutical company; clients across the healthcare space . growth projection model and pitch (2) Developed gene therapy strategy Performed valuation analyses including deck, providing basis for Series B for large-cap biotech company; (3) DCF analyses, public comparable analyses fundraising negotiations . Applied Supported top-10 multinational pharma and precedent transaction analyses . product design thinking principles company in developing patient support Drafted fairness opinion presentation with CTO to create proposal for soft- program generating 2:1 ROI and materials . ware to train dermatology students . reaching over 160,000 patients .

9 Jordan Brown William D. Burton Evan Cairo [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Brigham Young University, Provo, UT The Wharton School, B .A ., Magna Cum Laude, Health and Societies, B A. ,. Cum Laude, Chemistry, 2014 University of Pennsylvania, Philadelphia, PA 2012 B .S ., Cum Laude, Finance, 2013

An opportunity to invest in and An opportunity to lead the operations An opportunity to build, invest in support the expansion of growth- of innovative and value-based health- and direct market-leading healthcare stage healthcare companies care services organizations. services companies.

Varian Medical, Palo Alto, CA J.P. Morgan, New York, NY Johnson & Johnson, San Francisco, CA Strategy & Corporate Development Intern, Summer Associate – Investment Banking, MBA Intern (Health Tech Partnerships), Summer 2019 Summer 2019 Summer 2019 Engaged in strategy development for Advised companies across healthcare Developed Apple partnership strategy leading radiation oncology medtech spectrum on strategic financial oppor- and recommended specific digital and software solutions provider . tunities . Worked on a large biotech opportunities within mental health Assessed strategic opportunities in buy-side process, a life science tools that contributed to a new Apple-J&J EMRs, data and technology-enabled sell-side process, and a healthcare collaboration . services . Evaluated medtech companies services IPO among other projects . for investment and acquisition . Led valuation analyses and financial Moelis Capital Partners, New York, NY modeling in addition to research and Private Equity Associate, 2016-2018 1315 Capital, Philadelphia, PA diligence efforts . Conducted industry, financial and MBA Intern, Summer 2018 business diligence to evaluate health- Evaluated healthcare services, medtech DaVita Medical Group, care investments for $1 3B. AUM private and specialty therapeutics companies Colorado Springs, CO equity firm . Developed investment for growth equity investment . Sourced Director and Sr. Manager– Operations, theses, managed third-party advisors, and introduced firm to hospital venture 2017-2018 arranged debt financing, negotiated organizations, resulting in investment As Director of Primary Care Operations credit & purchase agreements, and opportunities and investor day and for a subsidiary of DaVita, Inc ,. I oversaw presented recommendations to invest- dinner . Conducted “white space a $40M P&L including a portfolio of ment committee . Executed platform analysis” and made recommendations primary care clinics and 60 providers; acquisition of Clearway Pain Solutions on identified investment sector . achieved 50% YoY operating income Institute, an interventional pain improvement . Had responsibility for management provider . Supported Northwell Ventures, Manhasset, NY day to day operations and strategic 3 portfolio companies by serving as Direct Equity Investments Analyst, turnaround initiatives . Additionally, a board observer, developing strategic 2016-2018 ran special projects related to opera- initiatives, monitoring financial perfor- Managed due diligence and tional and financial performance of mance, and evaluating M&A targets . investment into 5 medtech and digital broader enterprise service lines . health companies through $50M Deloitte Corporate Finance, New York, NY corporate venture capital allocation DaVita Inc, Denver, CO Investment Banking Analyst, 2013-2016 (Seed to Series B) . Supported portfolio Sr. Analyst and Analyst – Corporate Strategy, Executed M&A transactions across company management on strategic 2014-2016 the healthcare sector including initiatives . Worked with Northwell Developed and advanced strategies Medtronic’s sale of its surgical instru- physicians and employees to spin-out for C-level executives and boards of ment business to Integra LifeSciences, technology and services into new, directors across multiple business units . Magellan Health’s acquisition of standalone ventures . On the medical group business line, TMG, and Astellas Pharma’s sale of led successful re-contracting efforts its commercial manufacturing business Retrophin, New York, NY for large hospital system worth $250M to Avara . Directed day-to-day execution Business Development Manager, 2014-2016 in annual spend and large physician of transactions, including creating Sourced and conducted diligence on group worth $15M in contribution go-to-market materials, managing 5 biopharmaceutical assets in rare margin . deal marketing processes, conducting disease for acquisition . Managed financial analysis, and coordinating out-licensing initiative in Asia-Pacific due diligence . region, including sourcing of partners and evaluation of term sheets .

10 Amanda L. Chin William J. Choi Rita Costiv [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Wesleyan University, Middletown, CT Northeastern University, Boston, MA B .A ., Magna Cum Laude, Biochemistry, 2015 B A. ., Economics, 2013 B .S ., Finance and Marketing, 2014 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, 2020

An opportunity to collaborate with An opportunity to invest in, partner An opportunity to develop and lead industry, hospitals, and payers to with, and build leading healthcare strategies designed to innovate current develop and integrate novel surgical services and technology companies healthcare practices with the goal of devices into clinical practice to provide improving quality of care and delivery safe and cost-effective care to patients. New Mountain Capital, New York, NY for both patients and providers. MBA Intern, Summer 2019 Boston Scientific Corporation, Conducted business diligence for Accenture Strategy, New York, NY Maple Grove, MN the acquisition of a provider of Senior Strategy Consultant, Summer 2019 Marketing Associate Intern, Summer 2019 revenue cycle management software . Collaboratively managed organization Developed a targeted strategy within Supported investment teams across design workstream during a pre-merger the US launch of the LOTUS Edge private equity, credit and net lease integration for a global biopharma- Transcatheter Aortic Valve System strategies . Accepted offer to return ceutical company undergoing an and the SENTINEL Cerebral Embolic full-time as a Senior Associate . acquisition . Developed training Protection System to engage with material, analyzed data and provided cardiac surgeons and valve clinic Vestar Capital Partners, New York, NY solutions to alignment complexities coordinators . Associate, 2016-2018 to ease facilitation of organization Evaluated and executed private equity design of the combined company . Hospital of the University of investments across healthcare, consumer Pennsylvania, Department of Surgery, and business services & industrial prod- Longevity Care, Inc., Newton, MA Philadelphia, PA ucts sectors as part of a team of ~25 Co-Founder, 2012-Current Clinical Research Assistant, 2016-Present investment professionals managing Co-founded and successfully developed Studied trends in open aortic surgery ~$5B of capital . Completed one a healthcare company providing for abdominal aortic aneurysm repair in platform acquisition of a provider of personalized home health care services the context of the growing prevalence network management and analytics to elderly and disabled adults with of endovascular aneurysm repair solutions to health plans and subse- the goal of minimizing their risk of (EVAR) . Findings were presented at quent add-on of a provider of physician hospitalization . Developed growth the Society for Vascular Surgery 2019 directory data accuracy solutions . strategies including expansion of Vascular Annual Meeting . Managed several portfolio companies company network and company across healthcare and business services relationships with outside organizations Navigant Consulting, New York, NY verticals, attending Board meetings, creating long term stability . Continuously Summer Intern, Summer 2014 monitoring performance, and driving redesigned and improved workflows Assisted clients in the pharmaceutical strategic and operational initiatives . and wage structures resulting in and medical device industries in a wide increased profitability . range of business issues including Perella Weinberg Partners, New York, NY market analyses, strategic planning, Analyst, 2014-2016 East Boston Neighborhood Health and business development . Initiated Conducted financial analyses and due Center, East Boston, MA the formation of a physician advisory diligence on mergers and acquisitions Operations Manager, 2016-2018 board for a global biopharmaceutical advisory assignments for clients across Co-managed a busy Family Medicine company planning upcoming Phase III the medical devices, life science tools department serving over 300 patients clinical trials of a novel drug for and diagnostics industries . Executed daily in the largest continental U .S . Crohn’s disease . two transactions across M&A and nonprofit health center . Optimized capital markets advisory . departmental workflows ensuring high efficiency and productivity amongst providers and support staff . Worked as a liaison between other specialty and support practices to improve care for patients and delivery support for providers .

11 William C. Davenport Elizabeth Katherine [email protected] M. Dunnigan Yale University, New Haven, CT A. Duckworth B .A ., Molecular, Cellular, and Developmental [email protected] [email protected] Biology, 2015 Claremont McKenna College, Claremont, CA University of Florida, Gainesville, FL B A. ,. Magna Cum Laude, M .S ., Biomedical Engineering, 2014 Science & Management, 2014 B .S ., Biological Engineering, 2013 Perelman School of Medicine at the University Accelerated 4+1 degree program of Pennsylvania, Philadelphia, PA M D. . Candidate, 2020

An opportunity to improve strategy and An opportunity to utilize clinical and An opportunity to strategically build operational efficiency for an innovative managerial skills to align stakeholder and scale innovative and evidence-based health care company. incentives across healthcare delivery healthcare solutions that improve the systems. efficiency and cost of care delivery. Professional Golf, Philadelphia, PA Tournament Golfer, Summer 2019 Butternut Box, London, UK Goldman Sachs, New York, NY Prepared to pursue short-term MBA Intern, Quality Assurance Investment Banking Summer Associate, professional golf aspirations with & Compliance, Summer 2019 Healthcare Group, Summer 2019 a competitive amateur tournament Analyzed compliance requirements for Advised top healthcare services and campaign . Won several events, the company’s expansion into the E .U . biotech companies on various transac- including the Philadelphia Mid-Amateur in hard-Brexit versus soft-Brexit scenarios tions, including a confidential filing Championship and National Mid- and shared recommendations with for an initial public offering of a Amateur Championship Qualifying, founders and Board of Directors . services company, due diligence on en route to an upcoming bid at Augmented back-end compliance potential strategic exit alternatives PGA Tour Qualifying School . systems, including reimagining the for a sponsor-owned spec pharma supplier on-boarding process, expanding company and valuation of a potential Boston Consulting Group, Miami, FL the company’s knowledge library and acquisition target for a large services Consultant, 2017-2018 building a suite of tools for measuring company . Associate, 2016-2017 compliance with E .U . requirements . Summer Associate, 2014 Advisory Board, Washington DC Transformed supply chain operations Bioactive Surgical, Baltimore, MD Strategy Consultant, 2018-2019 of a major biopharmaceutical company, Research Assistant, 2014 Advised payors and providers on including supply planning, logistics, Collected pre-clinical data to support strategic initiatives, including growth and life cycle management of the an Innovative New Drug application to strategy of a patient navigation company’s most prominent drugs . the U S. . Food and Drug Administration . program to increase patient loyalty Assessed and advised digital biometry Performed in-vitro experiments, and reduce leakage, business plan strategies for a French biotech including maintaining stem cell lines development for a potential joint company . Contributed to BCG’s and conducting cell viability assays, as venture for a large health system, published knowledge base on well as processing animal tissue samples pricing strategies with a focus on operational efficiency in health and coordinating future animal studies . transparency and Medicare Advantage care and worked in over 15 countries, strategic partnerships . including a year based in the Steelcase Inc., San Francisco, CA Melbourne office . Intern, WorkSpace Future & Corporate Accenture, Dallas, TX Strategy, 2012 Management Consultant, Life Sciences, Conducted primary and secondary 2016-2017 research on innovation, investment Analyst / Senior Analyst, Life Sciences, models, organizational structure and 2014-2016 work culture trends in Silicon Valley Advised top pharma companies on to help the world’s largest office compliance strategies for new global furniture manufacturer understand serialization regulations . Select experi- and adapt to the future of work . ences: created $50M serialization budget, coordinated change manage- ment across ~20 global packaging sites, developed internal North America Life Sciences people program .

12 Jennifer L. Fernández Annie M. Fox Charles J. Gage [email protected] [email protected] [email protected] American University, Washington, DC Amherst College, Amherst, MA University of North Carolina, Chapel Hill, NC B .A ., Cum Laude, International Studies and B A. ., Neuroscience, 2014 B .S ., Business Administration and Economics, Business Administration, 2013 2013 University of Pennsylvania, Philadelphia, PA J .D . Candidate, 2020

An opportunity to work with and An opportunity to improve health care An opportunity to improve care delivery within strategic organizations to drive access and quality through strategic and and health outcomes through techno- improvements and innovations in care technological innovation. logical innovation, strategic decision- delivery and healthcare outcomes. making and operational excellence. Manatt Health, New York, NY GlaxoSmithKline, Philadelphia, PA Summer Analyst, Summer 2019 Boston Consulting Group, Atlanta, GA Esprit Pharmaceutical Commercial Intern, Collaborated with a range of care Summer Consultant, Summer 2019 Summer 2019 organizations (hospitals, medical Transformed complex military aviation Performed market assessment to schools, research institutes) on organization through data analysis define trends and product portfolio strategic planning; performed data and application of commercial best sales growth opportunities in the retail analysis and current state assessments practices . Planned and conducted pharmacy and clinic space . Developed and drafted organizational and innovation workshop and pitch a strategic plan and advised large financial models for a joint venture . competition for 24 enlisted military cross-functional team on tactical personnel, resulting in fleet-wide recommendations to evolve organiza- Population Council, Lusaka, Zambia adoption of winning idea that will tional procedures to support product Global Health Corps Fellow, 2017-2018 save 6,000 man-hours per year . education and sales efforts in the Served as Director of Growth for a Developed metric report set for retail setting . Kenya-based digital health startup performance evaluation of aircraft and as an Informatics Officer for a maintenance crews . Deloitte Consulting, Washington, DC Zambian non-profit . Led first-ever Senior Consultant, 2018 user acquisition strategy for core Huron Consulting Group, Washington, DC Consultant, 2016-2018 digital product; established 80+ person Associate, 2015-2017 Business Analyst, 2015-2016 task force and increased product users Analyst, 2013-2015 Worked on 6+ strategic and operational 900% in 3 months . Evaluated a $10M Led teams of analysts on Revenue projects across two Federal healthcare initiative to increase Zambia’s family Cycle performance improvement, agencies . Primary project areas planning services; identified opportu- technology implementation and post- included: oversight and execution of nities to improve supply chain merger integration strategy projects a maturity assessment of a primary efficiency and patient satisfaction, resulting in $150M+ cumulative benefit care patient centered medical home reporting to Ministry of Health and for 8 health systems and associated model, formation of a strategic plan United Nations Population Fund . physician groups . Performed extensive for trauma care in the U .S . Navy, and data analysis to isolate payer trends, development and implementation of a Genoa Telepsychiatry (UnitedHealth), reduce denials and increase cash flows . performance management framework New York, NY Designed and built hybrid in-house to support quality and safety strategic Physician Partnerships Manager, 2015-2017 self-pay collections team and vendor initiatives . Led teams of consultants to Led strategy to grow national physician outsourcing model for hospital client . support program and performance network, increasing provider partners Daily interaction with client managers, management efforts across multiple 500% in 1 year . Co-led scaling of internal directors and executives . workstreams . Physician Partnerships team, setting team vision and designing and imple- Biotechnology Industry Organization, menting organizational structure . Washington, DC Coordinator, 2013-2015 Brigham and Women’s Hospital, Oversaw development of company Boston, MA presentation programming for 6+ Neurology Research Assistant, 2014-2015 annual industry trade conferences, Co-led clinical research study, and managed outreach, marketing, collecting, processing, and analyzing and communications to over 6,000 brain wave data for 100+ participants . biotechnology and pharmaceutical executives .

13 Reena E. Glaser Jan Gong Michael P. Greenberg [email protected] [email protected] [email protected] Princeton University, Princeton, NJ Harvard College, Cambridge, MA University of Pennsylvania, Philadelphia, PA A .B ., Summa Cum Laude, Psychology, 2014 A .B ,. Magna Cum Laude, Chemical and B .A ., Biological Basis of Behavior, 2012 Physical Biology, 2015 B .S ., Economics (Finance Concentration), 2012 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M D. . Candidate, 2020

An opportunity to create equitable An opportunity to use my experience An opportunity to build innovative access to healthcare via digital customer in clinical practice and basic science healthcare companies as an investor experience. research to bring innovative therapeutics or strategy professional. to market. Cerner Corporation, Kansas City, Genentech, South San Francisco, CA Missouri Commodore Capital LP, New York, NY Business Development Summer Associate, Product Manager, Summer 2019 Investment Analyst Intern, Summer/Fall 2019 Summer 2019 Developed market strategy, business Conducted investment diligence of Created business development strategy case and technical requirements for small- and mid-cap biotechnology and comprehensive landscape analysis to patient-to-provider messaging product companies . enable novel partnering and investment line in $19B patient engagement transactions within neuroscience . market . Modeled proof of concept Marshall Wace LLP, New York, NY Conducted diligence screens and term for one-way and two-way text Investment Analyst Intern, Summer 2019 sheet negotiations and supported messaging applications . Conducted investment diligence of cross functional teams composed of biotechnology and pharmaceutical internal scientific researchers, in-house Deloitte Consulting, Arlington, VA companies as part of the Global legal counsel, and finance team members Consultant, 2016-2018 Healthcare Team . to execute research collaborations, Managed technical team of 5 to MTAs, and in-licensing deals . engineer an access to care dashboard RTW Investments, LP, New York, NY to proactively reduce wait times across Biotechnology Research Intern, PureTech Health, Boston, MA 170 medical centers . Convened 20 Winter/Spring 2018 Director, Strategy and Corp Dev, 2018 R&D experts to establish a formal Identified and evaluated candidate Senior Manager, Strategy and Corp Dev, 2017 process accelerating clinical product diseases and targets for novel gene Manager, Strategy and Corp Dev, development and distribution for therapies to support portfolio companies . 2016-2017 an international hospital network . Led diligence process in respiratory and infectious disease space resulting in Deloitte Consulting, Arlington, VA initial investment, company formation Business Analyst, 2014-2016 and eventual IPO of new portfolio Advised hospital C-suite on distribution company, resTORbio (NASDAQ:TORC) . of $234M budget and 2,700 employees Developed capital allocation strategies to meet patient demand . Constructed to support investment decisions and predictive time series models and metric long-term growth for the firm . definitions for 12 industry benchmarks Managed disease-area prioritization to monitor $50B budget allocation for multiple portfolio companies, across a global health system . Devised resulting in redirection of venture implementation planning and reporting financing proceeds towards development strategy for national cancer prevention in multiple additional disease areas . and screening programs at a public health agency . Leerink Swann Consulting, New York, NY Managing Consultant, 2015-2016 Senior Consultant, 2014-2015 Analyst, 2012-2014 Advised senior executive biopharma clients on a range of strategic business projects such as financial valuations, pipeline prioritizations, asset scans, and competitive landscape assessments .

14 Christopher Alexandra M. Hariri Elston He H. Greeno [email protected],edu [email protected] Princeton University, Princeton, NJ Harvard College, Cambridge MA [email protected] A .B . Ecology and Evolutionary Biology, 2013 A .B ., Cum Laude, Philosophy, 2013 Williams College, Williamstown, MA Georgetown University, Washington DC University of Pennsylvania Law School, Phila- B .A ., Cum Laude Biology and Economics, 2014 M S. . Biotechnology, 2017 delphia, PA J .D . Candidate, 2020

An opportunity to bring new products An opportunity to bring novel, innovative An opportunity to build products and to patients at innovative biotechnology therapies to patients through business invest in companies that improve health or life sciences companies in a business development in the biotechnology outcomes and costs through innovation development or operations role. industry. Roivant Sciences, New York, NY BridgeBio Pharma, San Francisco, CA Cornell University Department Product Manager | Strategic Investments, Business Development Intern, Summer 2019 of Neurosurgery, New York, NY Summer 2017-Present Drove business development and Intern, Summer 2019 Own data analytics product for clinical commercial strategy projects for two Gained clinical experience and trial risk assessment and operational of BridgeBio’s lead subsidiaries: QED operational insights while alongside feasibility, utilizing data from thousands Therapeutics and Origin Biosciences . the chair of the department of neuro- of previous trials across phases and Engaged in partnership discussions, surgery in both the outpatient setting therapeutic areas – a core offering of conducted diligence and handled and the operating room . Gained a multi-year, $10+M product develop- requests from potential partners . Led perspective on the evolving challenges ment deal . Diligenced $20M opportunity analysis of Origin’s E .U . commercial in managing a world-class academic for next-generation clinical trials solution opportunity, reimbursement pathways surgical department . utilizing NLP to extract EHR data and and partnership strategy . Owned com- enroll eligible oncology patients across petitive intelligence analysis for QED’s Celularity, Warren, NJ under-penetrated trial sites . oncology indications, guiding updates Corporate Strategy and Business to confirmatory trial designs . Development, Summer 2018 Guggenheim Partners, New York, NY Identified potential competitors and Associate, 2015-2017 Clarion | A Life Sciences Consultancy, partnerships relevant for the company’s Led due diligence, structuring, and Boston, MA therapeutic assets . execution for multiple investments Consultant, 2017-2018 across a wide spectrum of products Senior Associate Consultant, 2016-2017 LifebankUSA (high yield, direct lending, structured Associate Consultant, 2014-2016 Associate Director of Business equity) and industries (healthcare, Led teams, managed clients and Development, 2013-2014, 2016-2018 consumer, financial services), deploying coached team members on 2-3 month Served as an associate in business over $100M+ in new investments for a growth strategy projects . Project development and marketing to create $12B credit fund . Provided healthcare highlights: (1) Led team in developing new strategic partnerships across 3 industry coverage, focusing on health- cash-flow model for lead asset of a business lines . Created new marketing care information technology, payors, digital therapeutics company . Model strategy including updating all and providers . used to support procurement of $60M promotional materials . in series-C financing . (2) Headed team Citigroup Global Markets, New York, NY to develop analytics-based market OXSTEM, Oxford, UK Analyst, 2013-2015 access assessment and payer targeting Business Development, September 2016 Developed firm’s research efforts in approach for $1B+ biologic . (3) Owned Conducted business intelligence the continuing care space, developing relationship and provided strategic research to identify possible collaborators tradable credit views and relative guidance to client at a top-5 pharma, and created term sheet . value pricing on all new issue bond overseeing design of a KPI tracking issuances across CCRC, SNF, and tool for a 100,000+ patient support Scientific American Publishing assisted living facilities . program . Project Management, 2014-2015 Developed web and print content for advertising and promotion campaigns . Planned and executed events for Worldview Magazine and served as editorial associate for Worldview ‘Future of Transportation’ Edition and Worldview 100 .

15 J. Andres Hernandez Scott Z. Heyman Olivia S. Jew [email protected] [email protected] [email protected] University of Central Florida, Orlando, FL The Johns Hopkins University, Baltimore, MD Stanford University, Stanford, CA B .S ,. Summa Cum Laude, Biomedical Sciences, B A. ,. Phi Beta Kappa, Public Health Studies, B .A . with Honors, Human Biology, 2014 2015 2012 Perelman School of Medicine at the University Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA of Pennsylvania, Philadelphia PA M .D . Candidate, 2019 M .D . Candidate, 2020

An opportunity to help patients through An opportunity to improve patient An opportunity to leverage my clinical cutting-edge surgical technique and outcomes in a strategic role that combines background and business experience thoughtful healthcare leadership. care delivery, patient engagement, and to enhance care delivery. technological innovations. University of Pennsylvania, Division Bain & Company, San Francisco, CA of Plastic Surgery, Philadelphia, PA Humana, Inc., Louisville, KY Summer Associate, Summer 2019 Sub-Intern, Summer 2019 Risk Management Intern, Summer 2019 Evaluated the cell therapy space for Completed clinical rotations at the Prepared research and initial draft of potential investment opportunities, Hospital of the University of white paper supporting proposed CMS work that was soon thereafter Pennsylvania, Massachusetts General and ONC legislation regarding data incorporated into Bain’s investment Hospital, and Duke Hospital, all interoperability . Defined Humana’s point-of-view . Modeled manufacturing focused on reconstructive plastic four core values for data sharing, capacity for a raw material for gene surgery . Continued research within identified accompanying business therapy in a multi-billion-dollar asset the field and converted team’s use cases and established performance diligence . Spearheaded the analysis of a operative experiences to projects metrics across four operational domains drug analog for a $1B+ client preparing which have resulted in publication . to measure success . a drug launch, including interviews with key stakeholders . University of Pennsylvania, Division of FTI Consulting, Washington, DC Plastic Surgery, Philadelphia, PA Director, 2017-2018 Children’s Hospital of Philadelphia, Research Associate, 2016-2019 Senior Consultant, 2014-2017 Philadelphia, PA Conducted surgical outcomes research Managed teams of consultants, Lead Investigator, 2016-2020 focused on reconstructive microsurgical designed project plans and oversaw Teamed with clinicians, hospital involvement in interdisciplinary execution or quantitative and qualitative leadership and software developers care teams, culminating in multiple analyses of large client data sets across to pilot a teledermatology mobile publications and national conference multiple platforms for use in econometric application that reduced wait times presentations . Additionally, designed analyses, health forecasting, antitrust by >180x . Executed a pilot for a and implemented study protocol enforcement and regulatory compliance . teledermatology consultation for focused on advanced imaging tools Drafted reports and presented results primary care providers that improved for analysis of surgical candidates to healthcare executives, lawyers and diagnostic accuracy for >40 patients . pre-operatively . government regulators for M&A Resulted in $185,000 in funding to transactions and litigation cases establish teledermatology program . Twine Labs, Philadelphia, PA exceeding $100M . Summer Business Operations Intern, 2016 Stanford Program in Human Biology, Spearheaded lead generation in Compass Lexecon, Washington, DC Stanford, CA early-stage startup focused on internal Analyst, 2012-2014 Course Instructor, 2014-2015 mobility, which resulted in company’s Utilized STATA, Excel and ArcGIS for Led structured discussion sections first users . Led promotions and statistical, economic, and geographical for >200 students, write exams and marketing, culminating in coverage analyses for antitrust cases . Developed mentor students on a team of 4 by multiple news outlets . charts and tables to summarize results instructors . Partnered with award- for expert reports and presentations winning Stanford department chairs for the healthcare, life science, tourism to reform curriculum and manage and manufacturing industries . Led conflict by ensuring transparency in meetings with clients/lawyers to the grading process . present analytical results for 15+ M&A transactions .

16 Yiqin Jiang Sam A. Kahn Kathryn H. Kelley [email protected] [email protected] [email protected] Williams College, Williamstown, MA University of Florida, Gainesville, FL Harvard College, Cambridge, MA B .A . Magna Cum Laude, Biology and M S. ., Finance, 2013 A .B ., Cum Laude, Human Evolutionary Psychology, 2013 B S. ., Finance, 2012 Biology, 2014 Peking University, Beijing, China Master of International Relations, 2017

An opportunity to have a high impact in Drive change through investing in and An opportunity to improve support for improving the lives of large populations helping build market-leading companies. global health startups and innovations of patients while touching the core to achieve scale provider-patient relationship Blackstone, New York, NY Private Equity Senior Associate, Gates Foundation, Seattle, WA Genentech, South San Francisco, CA Summer 2019 MBA Intern, Summer 2019 MBA Commercial Summer Associate, Member of the Private Equity team . Led assessment of how the Vaccine Summer 2019 Participated in all aspects of the Delivery team can better support Spearheaded development of patient- investment process, including thesis global health startups achieve scale . facing digital assets (website, display development, conducting financial Conducted interviews with startup banners and SEM) for rare-disease and business due diligence, and CEOs, global health investors and experts indication by aligning a broad team presenting to the firm’s investment to understand gaps and challenges as of agency and internal partners with committee, ultimately leading to the well as interviews with different teams the patient journey and brand strategy . completion of a new platform invest- at the foundation to learn about the ment . Received and accepted offer to various creative financing techniques Palladium, New York, NY return full-time . they employ . Presented findings and Senior Consultant, 2017-2018 recommendations to senior leadership Consultant, 2015-2017 GI Partners, San Francisco, CA within Global Delivery Programs . Associate Consultant, 2013-2015 Private Equity Senior Associate, 2015-2018 Advised and coached public and Member of the Healthcare Private Trinity Partners, Waltham, MA private organizations across several Equity team . Completed 2 multi-asset Consultant, 2016-2017 industries on execution and monitoring platform investments, 5 add-on Senior Associate Consultant, 2015-2016 processes (such as strategy maps, acquisitions, 2 debt re-pricings, 1 Associate Consultant, 2014-2015 scorecards and initiative prioritization) secondary public offering, and 2 Advised leading and emerging designed to help them achieve their multi-LP co-investments . Oversaw pharmaceutical and biotech firms long-term strategies . Specialized in 4 portfolio companies, monitoring across dozens of therapeutic areas . developing ecosystem-based strategies performance and partnering with Completed 30 projects focusing on for biopharma multinational companies management teams to execute value qualitative and quantitative market to succeed in emerging markets by creation plans . research, strategic planning, roadmap integrating financial and social out- launch planning, forecast creation, comes . Led consulting engagements as Jefferies, New York, NY prioritization and competitive strategy . primary client relationship and project Investment Banking Analyst, 2013-2015 Managed 2-3 associates per project manager . Additionally, served as internal Member of the Mergers & Acquisitions on 16 projects . Project highlights: 1) regional Chief of Staff, with purview team . Executed 6 M&A transactions Co-led a $500K engagement with a over strategic planning and execution, representing over $5B in transaction Fortune 500 company; improved and new product development, cross-func- value across the healthcare, technology, supported quarterly forecasting cycles tional integration and internal commu- industrials, and consumer sectors . for key oncology product worth nications . $450M in annual sales, 2) Developed strategic launch plan roadmaps for two orphan products; traveled to Brussels to conduct launch planning workshops with senior executives .

17 Garrett M. Klein Zachary M. Laskin Andrew D. Lay [email protected] [email protected] andrew .lay .wg20@wharton upenn. .edu Swanson School of Engineering at the Washington University in St . Louis, St . Louis, MO Duke University, Durham, NC University of Pittsburgh, Pittsburgh, PA B S. B. A. ,. Finance, Healthcare Management, 2013 B .S ., Biology, 2013 B .S ,. Summa Cum Laude, Industrial Engineering, 2013

An opportunity to improve healthcare An opportunity to transform the delivery An opportunity to contribute to the through an investing role. of healthcare through operational and strategy and operations of health technological innovation. care delivery organizations and to the Newbrook Capital, New York, NY success of entities and patients that Hedge Fund Summer Analyst, Summer 2019 Boston Consulting Group, Summit, NJ support, invest and depend on them. Led diligence of investments in consumer Summer Consultant, Summer 2019 discretionary, consumer staples, Advised a multi-state payer on a network Oliver Wyman, San Francisco, CA e-commerce, auto parts and cannabis optimization strategy to support a Summer Associate, Summer 2019 sectors for a $2B AUM long-short 30% claim cost reduction target . Developed a 5-year service line strategy equity hedge fund with a twelve-year Analyzed hospital and ambulatory roadmap for a $3B regional health track record surgical center performance in core system, delivering an innovative coverage area to determine where approach to front door clinical access, Advent International, Boston, MA care could be diverted to improve recommendations for physician practice Private Equity Associate, 2016-2018 quality and reduce cost . redesign, and guidance around Evaluated investments requiring optimizing care team ratios and overall $250M-$1,000M+ of equity, primarily Eden Health, New York, NY provider staffing . Collaborated to in the healthcare sector (services, Operations Intern, Summer 2018 build a service line analytics model, pharma, behavioral) . Responsibilities Supported the Chief of Staff and CEO combining claims data and actuarial included financial modeling, conducting on customer acquisition by analyzing analysis to project future demand for company and industry due diligence, potential commercial customers’ medical health care services to inform capacity leading financing, accounting and claims to derive potential savings from planning, site allocation and partnership consulting workstreams, managing improved primary care utilization by strategy . portfolio company operational initiatives employees . and presenting to investment committee . MAXIMUS Inc., Reston, VA Supported 2 portfolio companies Pomona Capital, New York, NY Manager – Strategy and Market (ATI Physical Therapy and Genoa Associate, 2016 – 2018 Development, 2017-2018 Healthcare), including leading a Managed all aspects of investment Senior Analyst – Business Development, $780M dividend recapitalization and process including industry research, 2015-2016 a $2B+ sale process . Submitted 2 final financial diligence, and investment Analyst – Business Development, 2013-2014 bids, one for a $500M autism services committee presentations for $1 .75B Led new business unit focused on provider and a second for a $3 .5B+ AUM private equity secondary fund evaluating potential adjacent markets Indian Pharmaceuticals Manufacturer . investing in other private equity and and managing development of new venture capital funds . solutions for MAXIMUS’ $1 .2B public McKinsey & Company, Pittsburgh, PA sector health services business segment . Business Analyst, Associate Secondee, Citigroup, New York, NY Served on project management team 2013-2016 Analyst/Assistant Vice President, for 5 new program implementations Advised clients from multiple industries 2014 – 2016 and redesigns, with responsibility for on strategic and operational issues; Performed strategic evaluations business process modeling, development led due diligence, managed teams and of Citi’s businesses and advised on of policies and procedures, staff partnered with senior management and executed proprietary Citi M&A modeling and production planning, teams . Performed analyses that transactions in the North America, and leading executive reviews . Managed informed key business decisions such South America and Europe . pricing, staffing and technology strategy as new market entry, private equity for 7 state/federal proposals with a investment decisions, business acquisi- total value of $250M . tions and divestments, salesforce optimization and R&D portfolio rationalization .

18 Harrison T. Lee Scott H. Lever Shuaiqing Liu [email protected] [email protected] [email protected] Princeton University, Princeton, NJ Pennsylvania State University, University Park, PA University of North Carolina at Chapel Hill, A .B . Magna Cum Laude, Chemistry, 2015 B S. ., Finance, 2012 Chapel Hill, NC Perelman School of Medicine at the University B .S ., Magna Cum Laude, Public Health of Pennsylvania, Philadelphia, PA & Applied Math, 2013 M .D . Candidate, 2020

An opportunity to lead and drive strategy An opportunity to build, lead and invest An opportunity to work in a strategic in a healthcare provider system, to in healthcare services companies that role in designing innovative healthcare improve the quality and operational are embracing the transformation to financing and delivery models through efficiency of care delivery. value-based care. technology applications

Boston Consulting Group, Philadelphia, PA Zenyth Partners, Great Neck, NY Health IQ, Mountain View, CA Summer Consultant, Summer 2019 Summer Vice President, Summer 2019 Product Innovation Intern, Summer/Fall 2019 Advised CIO of a Fortune-500 chemical Evaluated potential investments in Performed system-wide needs assessment company on an affordability PMO for managed care, specialty physician and successfully identified 4 opportu- IT operating costs . Created a financial services, dental services and healthcare nities to engage with payer, provider, model to forecast and create account- IT for middle-market healthcare services consultants, and population health ability for $69M in savings across private equity firm . Developed and companies in entering the healthcare multiple service line initiatives and presented in-depth investment thesis space . Created Medicare-related policies conducted industry benchmarking focused on sub-sectors within the that save up to 42% in premiums for to pressure-test savings targets . value-based care ecosystem . Drove seniors living a healthy lifestyle . deal process for a potential investment Worked along the insurance product Penn Medicine Center for Health Care in a managed care startup, including cycle from insurer/reinsurer partnership Innovation, Philadelphia, PA developing the financial model, formulation to sales, marketing, and Medical Intern, Summer 2016 spearheading due diligence process, operations integration . Product will Refined the care delivery model for and validating company assumptions . launch in over 30 states by end of 2019 . the Penn Health First Clinic, a technology- Independently sourced HCIT investment enabled primary care clinic for employ- opportunities through direct outreach Aon Consulting, San Francisco, CA ees . Piloted strategies for improving to founders . Specialist, Analyst, Consultant, Senior efficiency in face-to-face physician Consultant & Actuary, 2013 - 2018 visits and performed contextual inquiry Marwood Group, New York, NY Led teams of consultants and actuaries for physician and patient adoption of Vice President, 2014-2018 managing 15+ employers’ health & virtual visits, finding opportunity in up Analyst, 2012-2014 wellness programs totaling $400M in to 42% of the clinic’s panel . Led consulting engagements and new annual budget . Worked closely with business development activity for a various parties in healthcare value United Community Clinic, Philadelphia, PA leading provider of healthcare consulting chain, including insurers/TPA, providers, Lead Medical Coordinator, 2015-2016 and M&A transaction diligence services . and population health management Led >25-person team to run a free Performed in-depth quantitative and companies to design and price group health clinic in West Philadelphia . qualitative private equity due diligence health plans . Spearheaded the first Spearheaded quality improvement involving payor reimbursement as well industry study quantifying cost efficiency projects to increase clinic efficiency as market and competitive analysis for of population health programs; receiving and capacity through workflow opti- over 100 healthcare services transactions industry recognition Launched Aon mization, ultimately yielding a 20% spanning 50 healthcare sub-sectors . Health’s technology industry vertical reduction in patient turn-around time . Launched new consulting division using BI techniques; aims to generate Won a Penn CAREs grant to establish through development of strategic $13M annual revenue in organic a diabetes screening program at the partnerships enabling the firm to growth . clinic . underwrite new insurance products for healthcare M&A deals ranging from $50M to $1B in enterprise value . Originally recruited by CEO to serve as Chief of Staff .

19 Thomas J. Marder Morgan E. Matthews Daniel G. [email protected] [email protected] McDonough Dartmouth College, Hanover, NH Harvard College, Cambridge, MA B .A ., Cum Laude, Neuroscience, 2012 A B. ,. Cum Laude in Field, Human Developmental [email protected] and Regenerative Biology, 2014 Georgetown University, Washington, DC B .S .F .S ., Magna Cum Laude, International Economics, 2013

An opportunity to support the An opportunity to support the launch An opportunity optimize and help development and commercialization of of transformative medicines and drug develop leading healthcare companies life sciences innovations in a business development platforms via commercial through investment. development or strategy role. or business development roles in pharmaceuticals and biotech. Citadel, New York, NY Regeneron Pharmaceuticals, Surveyor Capital Summer Associate Tarrytown, NY TrialSpark, New York, Summer 2019 New Products Planning MBA Intern, NYStrategic Partnerships Intern, Initiated coverage on the Contract Summer 2019 Summer 2019 Research Organization (CRO) sector Developed operational launch plan Executed high-impact operations project with investment recommendations for for ultra-rare disease asset through ahead of schedule for digital contract the sector’s 6 publicly traded companies . one-on-one meetings and workshop research organization . Mapped patient Performed market diligence and with over two dozen internal experts scheduling process and built financial individual company analyses to identify across commercial, medical and R&D model . Recommended operational dislocations between fundamental functions . Planned unbranded campaign improvements totaling $3M in near-term equity valuations and consensus focused on improving patients’ and savings to senior leadership . Led cross- expectations . physicians’ understanding of disease functional workshop to drill-down into mechanism . proposed solutions, increase firm-wide GTCR, Chicago, IL visibility and align on go-forward plan . Senior Associate, 2017-2018 Putnam Associates, Boston, Ran scientific and commercial due Associate, 2015-2017 MA and San Francisco, CA diligence for potential pharmaceutical Evaluated and executed private equity Consultant, 2017-2018 acquisitions . investments for GTCR’s healthcare Senior Associate Consultant, 2016-2017 group, which included work that Associate Consultant, 2014-2016 Putnam Associates, Boston, MA spanned healthcare’s subsectors . Led project teams in executing Consultant, 2017–2018 Developed particular focus on the commercial and corporate strategy Senior Associate Consultant, 2016–2017 life science tools space through four engagements for leading biopharma- Associate Consultant I – Associate completed acquisitions and thesis ceutical companies . Completed over Consultant II, 2014–2016 development work related to genomic 25 projects, including competitive Led diverse project teams through all therapeutics and molecular diagnostics . landscape assessment, market oppor- stages of pharmaceutical and biotech Managed portfolio companies by tunity analysis, forecasting, clinical client engagement, balancing needs coordinating with senior executives, trial design, and payer contracting of internal and external stakeholders . attending board meetings, and tracking approach . Drove project thought leadership in core metrics to monitor company key strategic domains, including: US performance . Joslin Diabetes Center, Boston, MA and ex-US pricing and payer strategy, Research Assistant, Department of Clinical, global asset launch preparation, sales Credit Suisse, New York, NY Behavioral, and Outcomes Research, force optimization, defensive counter- Analyst, 2013-2015 2012-2014 strategies and competitive positioning . Analyzed and executed mergers, Completed data collection and statistical Therapeutic areas span vaccines, leveraged buyouts, and recapitalizations analyses for four-year NIH-funded oncology, CNS disorders, autoimmune, for healthcare corporations and financial study investigating imaging-based infections and cardiovascular disease . sponsors to support the firm’s healthcare Alzheimer’s disease diagnostics in coverage group . Transaction focused patients with diabetes . Published two Brack Lab, MGH, Boston, MA on the specialty pharmacy space, scientific manuscripts and contributed Research Intern, 2012-2014 which included an acquisition financing to two funded grant applications Wrote thesis quantifying the temporal and an initial public offering . totaling $325,000 . mechanics and asymmetric fate determinations of muscle stem cells .

20 Jennifer Morganroth Elizabeth L. Morse Diana C. [email protected] [email protected] Mosquera, M.D. University of Pennsylvania, Philadelphia, PA Dartmouth College, Hanover, NH B .A ., Magna Cum Laude, Economics, 2013 B A. ., Cum Laude, Biology with Honors, 2015 [email protected] Perelman School of Medicine at the University Stony Brook University, Stony Brook, NY of Pennsylvania, Philadelphia, PA A .B ., Cum Laude, Economics, 2009 M .D . Candidate, 2020 Weill Cornell Medicine, New York, NY M .D ., 2014

An opportunity to implement innovative An opportunity to advance innovations An opportunity to develop and implement solutions to improve healthcare delivery for personalized medicine, promoting value-based payment and care redesign for patients and physicians. collaborations to integrate genomic strategies in a healthcare organization approaches with drug development to that aims to achieve the quadruple aim. EpilepsyCo, a 4 Catalyzer Company, guide healthcare decisions New York, NY Penn Medicine, Philadelphia, PA Commercial and Clinical Team Lead Regeneron Pharmaceuticals, MBA intern, Office of the CEO (Summer 2019), Consultant (2019- present) Tarrytown, NY Summer 2019 Led clinical and commercial activities Business Leadership Development Internship, Reported directly to the VP of for a Series B start-up creating a non- New Products Strategy, Summer 2019 Managed Care while tasked with invasive epilepsy monitoring device . Independently developed NSCLC business analyzing value-based payment strategy Coordinated communication between case including situational analysis, across multiple models and payers . the clinical operations and product revenue model, and marketing playbook . Assessed financial risk and gain oppor- engineering teams to ensure that the Collaborated with a cross-functional tunities across current and upcoming software and hardware functionality team to develop a tactical brand plan . value-based initiatives . Developed of the prototype device met clinical Led cross-functional tactical workshop recommendations based on Penn goals . Conducted interviews with for alignment on scenario planning Medicine’s strengths, population health patients and physicians to inform and to optimize investment . infrastructure and market position . product design and user experience . Longitude Capital, Greenwich, CT Penn Medicine, Philadelphia, PA Department of Neurology, NYU MBA Intern, Winter/Spring 2019 Attending Physician, 2018- Present Langone Medical Center, New York, NY Developed scientific framework to eval- Supervise and train resident physicians Research Data Associate, 2013-2014 uate novel oncology modalities, analyzed in the specialty of Anesthesiology and Developed a primary database for the clinical development landscape and Critical Care in an Academic Medical concussion research registry and sideline assessed recent deals to monitor current Center environment . Member of ACGME testing in youth athletes for over 1000 market landscape . Sourced strategic Patient Safety Collaborative to engage participants, culminating in presenta- investment opportunities for $1 .2B resident physicians in quality improve- tions and publications . Led education biotech-focused venture capital fund . ment . Recruit and select residency outreach to develop community-wide applicants as a member of the Penn concussion awareness . Selected to ClearView Healthcare Partners, Anesthesiology residency admissions attend The United Nations Concussion Newton, MA committee . Awareness Summit, an event focused Senior Consultant 2018, Consultant 2017-2018 on the future of concussion policy and Senior Analyst 2016-2017, Analyst 2015-2016 Penn Medicine, Philadelphia, PA research . Biopharma strategy consultant leading Resident Physician, 2014-2018 growth strategy projects, including Developed clinical and procedural NYU Langone Epilepsy Center, portfolio prioritization, due diligence, skills necessary to provide anesthetic New York, NY revenue forecasting, scenario analysis, care for patients undergoing complex Research Assistant, Summer 2012 and post-merger integration work- surgeries at a quaternary hospital . Conducted patient centered outcomes streams . Founded corporate responsi- Managed teams of residents and research to categorize patients with bility initiative and chaired Women CRNAs caring for medically unstable treatment resistant epilepsy into a Leadership program . Project high- patients . Developed checklist for safe surgical grading scale . lights: (1) Analyzed buying process for care transition of patients arriving in CDx platform to prioritize tumor market Post Anesthesia Care Unit . segments; (2) Led tumor microenviron- ment competitive landscape assessment informing scenario planning and positioning; and (3) Evaluated genitourinary pipelines for late-stage partnership opportunities .

21 Misha Kristen E. Nehls Ilana Nelson-Greenberg Nasrollahzadeh [email protected] [email protected] Dartmouth College, Hanover, NH Brown University, Providence, RI [email protected] B A. ,. Magna Cum Laude, Biology, 2014 B .A ., Development Studies, 2010 Stanford University, Stanford, CA Bryn Mawr College, Bryn Mawr, PA B .S ,. Management Science & Engineering, 2013 Post-Baccalaureate Degree, Pre-Medical Sciences, 2015 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate, 2020

An opportunity to build technology- An opportunity to bring novel An opportunity to integrate clinical enabled healthcare products, services therapeutics to market. insights with healthcare delivery and operation models that address systems to bring greater access to social determinants of health, with Regeneron Pharmaceuticals, care to underserved populations. a focus on food-based solutions. Tarrytown, NY MBA Intern in New Products Planning, Partners In Health, Haiti/Boston, MA Walmart, Bentonville, AR Summer 2019 Haiti Program Coordinator, 2013-2014 Health & Wellness Strategy and Operations Collaborated with large cross-func- Responsible for health program imple- Intern, Summer 2019 tional team to develop 2020 strategic mentation across 10 clinical sites in Pitched, researched and designed and tactical brand plan for a late stage Haiti, with a $40M annual budget, “GroceryRx” program, an in-store therapeutic . Synthesized research and working with diverse national and food-as-medicine offering integrating perspectives from across the organiza- international public/private partners Walmart grocery, pharmacy and newly tion to develop strategic plan and to execute clinical, operational, launched clinic arms . Received leadership worked with various stakeholder development, communications, approval to run proof-of-concept in groups to gain alignment on path and training programs . Fall 2019 in two stores in Georgia . forward . Conducted in depth competitive analysis to inform strategy as well as Hopital Universitaire de Mirebalais, Haiti Castlight Health, San Francisco, CA quantitative analysis to determine the Project Coordinator, 2012-2013 Senior Product Manager, 2017-2018 asset’s market potential . Led administrative and programmatic Product Manager, 2016-2017 support for executive and leadership Launched UI for Castlight Complete Oliver Wyman, New York, NY teams, during planning and opening and Anthem Engage, combined plat- Engagement Manager, 2018 phases of a 250,000 square foot 300- form of healthcare transparency and Associate, 2016-2018 bed state of the art teaching hospital wellbeing products for self-insured Senior Consultant, 2015-2016 in Mirebalais, which served as a referral employers, accounting for $10M in Consultant, 2014-2015 site for 3 .4M people, and as a training Q12018 sales . Led vision and execution Conducted 10+ strategic and operational program for Haitian residents . for website redesign, increasing NPS projects across broad industries including: from -6 to 30 . Rebuilt registration and financial services, logistics manage- Shining Hope for Communities, onboarding for 1M users, reducing call ment, telecommunications and media, Kibera, Kenya center volumes by 30% . Served on and the fine arts . Primary focus areas Health Services Director, Johanna Justin committee to integrate Castlight and included customer base management Jinich Community Clinic, 2010-2011 acquired company Jiff . in subscription businesses, specifically Helped lead strategic planning and managing customer acquisition, cross program development for a new com- Palantir Technologies, Palo Alto, CA sell and retention through marketing munity health clinic in Kibera, Kenya, Deployment Strategist, 2013-2016 and sales initiatives . Led teams serving over 10,000 patients in its first Led a team of 8 engineers, designers of consultants on qualitative and year . Hired and supervised a 15 person and data scientists to build fraud quantitative analysis, with heavy staff . Developed clinical, community investigation platform for Fortune 50 use of big data to inform decisions . health worker and volunteer programs health insurance client . Pitched roll- and oversaw daily clinic operations . out strategy to COO, securing first payor partnership . Designed and exe- cuted dashboard for clinical trial asso- ciates to improve patient recruitment for Fortune 50 pharmaceutical client .

22 Natalie E. Pancer Alomi O. Parikh Arpan A. Parikh, M.D. [email protected] [email protected] [email protected] Yale University, New Haven, CT Princeton University, Princeton, NJ The Ohio State University, Columbus, OH B .S ,. Biomedical Engineering, 2014 B A. ., Summa Cum Laude, Chemistry, 2015 B .S . with Honors, Biology, Summa Cum Laude, Perelman School of Medicine at the University 2011 of Pennsylvania, Philadelphia, PA M .D ., 2013 M D. . Candidate, 2020

An opportunity to work in strategy and An opportunity to combine insights An opportunity to innovate the delivery business operations at the intersection of from clinical practice with a knowledge of high-quality behavioral healthcare t life science and technology innovation. of health care management in order to o reduce stigma and increase access, improve health care delivery systems. both as a practicing clinician and as an PicnicHealth, San Francisco, CA operational/strategic leader. Partnerships/Strategy Intern, Summer 2019 McKinsey & Company, Jersey City, NJ Designed two IRB-approved real world Summer Associate, Summer 2019 CareMore Health, New York, NY evidence studies, and product managed Advised global pharmaceutical company Summer MBA Consultant, Summer 2019 launch across engineering, design, and on assessment and prioritization of all Developed and launched a clinical partnerships teams . Led company lead- opportunities in the R&D pipeline . workflow streamlining and operation- ership through analysis and discussion Provided deep dives on target disease alizing the identification and treat- of new business development strategy, areas and led working sessions with ment of patients with substance use leading to outreach of new potential R&D client teams . Built and maintained disorders in 3 markets serving 20,000 biopharmaceutical partners . a database of qualitative assessments patients . Revised comprehensive of each opportunity . Facilitated final psychiatric medication guidelines for Pfizer, New York, NY data delivery and visualization to aid distribution to all primary care and Consulting & Execution Manager decision-making at the senior level . behavioral health clinicians . (2017-2018), Analyst (2015-2017) Led strategy and operational improve- Perelman School of Medicine at the Icahn School of Medicine at Mount Sinai, ment projects approved by the CEO University of Pennsylvania, New York, NY or executive team across research, Philadelphia, PA Assistant Professor, Department of development, and commercial functions . Research Intern, 2016-2019 Psychiatry, 2017-Present Partnered with internal clients to Designed and implemented multiple Actively practicing, board-certified define their business challenge, quality improvement projects in psychiatrist treating patients on acute develop solutions, and implement departments at University of inpatient psychiatric units across 2 recommendations . Primary focus areas Pennsylvania hospitals as part of hospitals . Served as Wellness Champion, included clinical development and multidisciplinary teams, including a identifying areas of critical burden on innovation . pathway to reduce time to seizure trainees and winning $75,000 grant treatment and a tool to improve award to co-lead program implemen- Beghou Consulting, New York, NY follow up in patients at high risk of tation to improve resident wellness Analyst, 2014-2015 vision loss . Conducted research in neu- and reduce burn out . Built sales and marketing Tableau rology and pediatric ophthalmology dashboards utilized by brand teams at that have resulted in peer-reviewed Addiction Institute at Mount Sinai- major biopharmaceutical companies . publications and national presentations . St. Luke’s, New York, NY Worked with clients to understand Medical Director, 2017-2018 sales analyses needed and wrote SAS Supervised 12-member cross-functional and SQL code to develop sales reports . treatment team and treated patients suffering from both psychiatric illnesses and substance use disorders . Revamped and instituted new referral and screening process for patients from both within and outside the Mount Sinai Health System .

23 Niyoshi P. Patel Parth D. Patel, D.M.D. Jason R. Peterson [email protected] [email protected] jason.peterson@[email protected] University of Pennsylvania, Philadelphia, PA University of Miami, Coral Gables, FL Yale University, New Haven, CT B .S ,. Magna Cum Laude, Economics, 2012 B A. ,. Cum Laude, Economics, 2014 B .A ., History and pre-medical studies, 2008 B .A ., Magna Cum Laude, Biology, 2012 University of Pennsylvania School of Dental Columbia University, New York, NY Medicine, Philadelphia, PA Master of Public Health, 2011 D .M D. ., 2018 School of Engineering and Applied Sciences at the University of Pennsylvania, Philadelphia, PA Master of Computer & Information Technology, 2020

An opportunity to build biotechnology Scale a multi-specialty dental services An opportunity to develop and invest companies developing groundbreaking company that delivers high-quality in premier healthcare organizations. therapies clinical outcomes, a consumer-focused experience and lasting societal impact. Capital Group, Los Angeles, CA bluebird bio, Cambridge, MA Summer Investment Analyst, Summer 2019 Business Development MBA Intern, Smile Culture Management, Researched and recommended equity Summer 2019 Philadelphia, PA investments with a focus on multi-year Developed and presented a cell therapy Co-Founder and CEO, 2015-Present risks and opportunities . landscape overview to key leadership; Furthered growth of Smile Culture, a Created a model to understand economic multi-specialty dental support organi- Roivant Sciences, New York, NY implications of third-party obligations zation . Executed multiple transactions Technology Investment & Innovation for new products in development for platform acquisition, launched Associate, 2017–2018 second de novo location and developed Co-founded corporate venture capital Purdue Pharma, Stamford, CT centralized infrastructure to support practice investing in Series A–C health- Senior Manager, Business Development platform growth . Currently lead a care technology companies . Sourced, & Finance, 2016-2018 team across 6 Greater Philadelphia diligenced and executed company’s Worked with team of investment locations, including 25 doctors and first investment as lead investor in professionals and executive manage- spearhead dual-growth strategies in $5M Series A financing . Implemented ment to diligence and complete M&A and de novo builds . Smile Culture “drug+digital development” program various acquisitions and collaborations; is on pace to treat over 35,000 patients where drugs were developed alongside Co-led the financial modeling, in 2019 . synergistic technology, leading to structuring, and negotiations for $110M in technology partnering a co-commercialization agreement University of Pennsylvania School of opportunities . on Symproic (treatment for opioid Dental Medicine, Philadelphia, PA induced constipation) Doctor of Dental Medicine Candidate, Texas Medical Center, Houston TX 2014-2018 Biodesign Innovation Fellow, 2015-2016 Athyrium Capital, New York, NY Completed doctorate program across Co-founded digital health company Analyst, 2014-2016 four years, including delivering care developing H .R . software for 100- Completed all aspects of diligence, within clinical units and completing nurse E .R . unit at world’s largest financial modeling, execution, and 6 rotations . Rotations included: Oral children’s hospital . management of investments for the and Maxillofacial Surgery, Orthodontics, healthcare-focused fund; Independently Periodontics, Pedodontics, Radiology Oppenheimer New York, NY sourced Clover Health as Athyrium’s and Endodontics . Awarded Penn Associate Director, 2014–2015 first healthcare IT investment (led to Dental Medicine’s Deans Scholarship Generated investment recommendations a successful exit for Athyrium) and attended externships at King’s across medical device, healthcare College in London and Tokyo Medical technology, distribution, labs, tools Great Point Partners, Greenwich, CT and Dental University . and diagnostics companies . Analyst, 2012-2014 Completed all aspects of diligence, BlackRock, New York, NY financial modeling, execution, and Portfolio Management Analyst, 2011–2014 management of investments for the Collaborated with portfolio managers healthcare services-focused fund; to manage $60B in assets for endow- Independently sourced Softbox ments and pensions . Generated three Systems as Great Point’s first ex-US executed trades . investment

24 William P. C. Rice Lora Rosenblum Ying Ying Shi, CFA [email protected] [email protected] [email protected] Northwestern University, Evanston, IL University of Pennsylvania, Philadelphia, PA University of San Simon, Cochabamba, Bolivia B .A ., Cum Laude, Economics, 2015 B A. ., Cum Laude with Distinction, Health B .A ., Economics, 2010 & Societies, 2012 EDHEC Business School, Nice, France M .Sc ., Finance, 2012

An opportunity to lead operations and An opportunity to scale patient outcomes An opportunity to lead a pharmaceutical strategy in a healthcare organization or and provider solutions by joining a company on its road to deliver innovative medical device company business development or growth strategy drugs and meet the evolving needs of team within a technology-enabled patients worldwide. McKinsey and Company, Charlotte, NC healthcare organization. Summer Associate, Summer 2019 Novartis, East Hanover, NJ Senior Business Analyst, 2017-2018 Cedar, New York, NY Summer Finance Associate, Summer 2019 Business Analyst, 2015-2017 Business Development, Summer 2019 Created a dynamic dashboard that Consulted multibillion dollar companies Designed go-to-market strategy for enabled monitoring of wholesaler and on a range of strategic and operational new business line . Ran and won RFP specialty pharmacy’s inventory levels topics . A highlighted selection includes: process for company’s first joint payer/ and automated calculations of related advising multiple hospitals on cost provider deal . Developed contract financial metrics . Leveraged momentum reducing strategies (e .g ., identifying language for new product offering . and advanced finance team’s digital margin negative procedures and ratio- journey on further analyses, e .g . nalizing supply chain spend), advising Flatiron Health, New York, NY marketing expenses and price-volume private equity firms on the suitability Operational Excellence Manager, 2016-2018 effects . Trained consultants and other and size of niche pharmaceutical Led internal initiatives to drive MBA interns . markets, advising insurance companies enhancements in company’s oncology- on how to revamp their customer specific software . Ran strategic Accenture Strategy, Munich, Germany experience and digital strategies, program for clients to achieve bonus Manager, 2018 advising hospitals on how to make reimbursements through federal Consultant, 2015-2018 a seamless patient experience, and initiative that rewards providers Led health care client teams in mergers advising two fortune 100 companies based on clinical outcomes . Managed and acquisitions projects, including a on potential cost synergies that could communication for entire physician EUR 1B pharmaceutical divestiture be achieved from a merger . network after announcement of Roche project and a health care services acquisition . company’s Transitional Service Agreement exit in 76 countries in Oscar Insurance, New York, NY Emerging Markets . Service Operations Lead, 2015-2016 Claims & Benefits Specialist, 2015 Clueda AG, Munich, Germany Customer Service Representative, 2014-2015 Chief Organization Manager, 2014-2015 Built and led five-person team to Advised CEO through preparation of resolve high-priority member issues company transaction, with ultimate such as urgent pharmacy transactions, merger by absorption into Baader pre-visit benefit clarifications, network Bank AG . complaints and denied claims . Scaled team processes to ensure consistent Alira Health, Munich, Germany service levels each year . Managed Project Manager, 2012-2014 national complaints department, Managed 10+ health care mergers supporting 145,000 members in four and acquisitions projects across 7 operating states . international offices, overseeing end- to-end project pipeline from market Wells Fargo, Philadelphia, PA research, preparation of long and Financial Analyst, Healthcare Financial short lists, target approach and due Services, 2012-2014 diligence . Created private equity Evaluated financial statements of database to streamline health care healthcare systems with over $500M investor search . in annual revenue .

25 Romana Sohail, F.S.A. Evan M. Strother Rishi Taggarsi [email protected] [email protected] [email protected] Lahore University of Management Sciences, Duke University, Durham, NC University of California, Berkeley; Berkeley, CA Lahore, Pakistan B S. ., Magna Cum Laude, Civil Engineering, B .A ., Political Economy, 2013 B .S ,. Mathematics, 2013 2013

An opportunity to identify and build A opportunity to build businesses that An opportunity to launch and scale successful healthcare businesses innovate in the US health care system. products in a dynamic healthcare tech- through a private equity investing role nology organization that improves the LLR Partners, Philadelphia, PA quality and accessibility of patient care Evercore Partners, New York, NY MBA Investment Intern, Health Care Private M&A Advisory Summer Associate, Equity, Summer 2019 Teladoc, New York, NY Summer 2019 Closed growth investment from $1 .2B Product Strategy Intern, Summer 2019 Conducted financial analysis, due fund in employee benefit technology Led development of business case for diligence, and M&A focused materials business . Developed firm-wide invest- a new “Virtual Primary Care” offering, development across clients in the ment thesis and strategy for healthcare including product definition, market healthcare, technology, and fintech payer technology sector . validation, clinical/operational risks & sectors mitigation plan, partnership strategy, FFL Partners, San Francisco, CA pricing and detailed financial forecasts . AXA – Global Healthcare, Singapore Operating Associate, Private Equity, Presented recommendations to full Manager, New Business Underwriting, 2017-2018 C-suite and senior leadership that 2015-2018 Worked with portfolio companies in crafted positioning for upcoming Evaluated 100+ investment opportunities $2 .0B fund on board-level strategic product launch . in healthcare and insurance sectors; initiatives . Example projects include: built multi-scenario operating models, (1) Building acquisition/de-novo CipherHealth, New York, NY conducted valuation analyses, and growth strategy and financial model Strategy & Analytics Lead, 2017-2018 managed third-party advisors . for Autism services businesses . (2) Recommended operational improve- Managed team of 3 associates and Developing product, go-to-market ments on patient rounding to senior analysts to synthesize findings and and pricing strategy for a health leadership at 14 health systems . Led debrief senior team members . care worker training business’s team of data scientists to conduct Prepared diligence question lists and first digitally-delivered solution . complex analysis on patient-level led diligence calls with management clinical outcomes data . Results at one of potential acquisition targets on Google, Inc, San Bruno, CA major health system showed 16 .3% targeted topics, including organization YouTube Product Specialist, 2016-2017 decrease in readmissions and 440 structure, competition, industry, Led product and operational initiatives identified patient issues . financials, sales and marketing and to improve YouTube for over >1 .8B products monthly viewers . Example project L.E.K. Consulting, San Francisco, includes designing and launching CA and London, UK Mercer, Singapore video reporting feature, which trains International Associate Consultant, 2016-2017 Consulting Senior Analyst, 2014-2015 machine learning algorithms to Associate Consultant, 2015-2016 Only Senior Analyst selected for client remove 30,000+ offensive videos Associate, 2013-2015 secondment, during the challenging per month . Evaluated Medicaid behavioral health period of PayPal’s spinoff from eBay . market opportunity in 24 U S. . states Negotiated eBay’s post-spin off health McKinsey & Company, Atlanta, GA for national payer; built pricing model insurance contracts, worth $2 .1M, in Senior Business Analyst, 2013-2016 used to pitch and close $172M funding 11 countries delivering 10% savings Executed critical strategy and operational of digital health startup; quantified Supported Asia Consulting Leader in initiatives for C-suite executives . Example market size for 5 digital health segments development of Asia’s 1st analytics- projects include: (1) Facilitating creation and recommended 8 startups for $20M based employee benefits model . of joint venture that provides cyberse- investment by large VC fund . Awarded Oversaw model implementation curity services to 150+ health care Consulting Magazine’s Excellence in for 40,000 employees in Philippines, companies . (2) Performing strategic Social & Community Investment for leading to 10% annual cost savings due diligence of mega-merger of two pro bono work for nonprofit hospice top 10 tech companies . provider .

26 Aaron J. Thomas Jennifer J. Thornton Shilpa Topudurti [email protected] [email protected] [email protected] Brigham Young University, Provo, UT Massachusetts Institute of Technology, University of Rochester, Rochester, NY B .S ,. Summa Cum Laude, Business Cambridge, MA B .S ., Cum Laude, Molecular Genetics, 2014 Management, 2012 B S. ., Biological Engineering, 2015 London School of Economics, UK M .Sc ., International Health Policy, 2015

An opportunity to lead within a mission- An opportunity to improve health care An opportunity to improve patient driven healthcare company building or by bringing innovative new therapies access to novel therapeutics by scaling transformative models of care to patients. strengthening collaboration between delivery or payment. life sciences and providers Blueprint Medicines, Cambridge, MA Eleanor Health, Waltham, MA Commercial MBA Intern, Summer 2019 Genentech, South San Francisco, CA Strategy and Operations Intern, Established market development Commercial Summer Associate, Summer 2019 strategy and tactical path forward for Summer 2019 Wrote a $2M proposal to deliver an investigational precision therapy in Created financial decision maker substance use disorder treatment and oncology . Assisted in early-stage brand targeted non-personal promotion recovery services for a state Medicaid planning efforts including marketing strategy for hematology/oncology program . Researched and created agency selection and brand vision . product . Managed creative agencies pitch deck materials outlining the ROI Facilitated a complex clinical trial during asset creation for product of Eleanor Health’s care model vs . decision through creation of a decision launch . Leveraged data analytics to existing care models . Developed framework and collaboration with clin- assess medication monitoring infrastruc- materials for and attended company’s ical, medical, regulatory and commercial ture capabilities at health systems in first board meeting . Led creation and stakeholders; resulted in core team order to develop solutions to improve implementation of company’s first agreement and recommendation patient access . information security and privacy policies . brought to the executive team . The Advisory Board Company (ABCO), Cohen Private Ventures, New York, NY Boston Consulting Group, Boston, MA Washington, DC Private Equity Associate, 2016-2018 Consultant, 2017-2018 Manager, Corporate Strategy Monitored existing and executed new Associate, 2015-2017 & New Product Development, 2016-2018 private equity, growth and venture Partnered with clients across health- Served as Chief of Staff to the CPO, capital investments for a $10B+ family care and other industries on strategic overseeing the successful technology office . Executed CPV’s first venture and operational consulting engage- product portfolio integration during capital investments and helped institu- ments . Conducted 10 due diligences Optum’s acquisition of ABCO . Provided tionalize the firm’s approach to venture to inform private equity investments near-term vision and strategy to chief investing . Trained 2 private equity from medical devices to biometric officers and board . Led concept design associates on quarterly reporting security . Led post-merger integration and testing for launch of clinical processes and monitoring 10 portfolio of R&D and HR departments for l decision support and post-acute care companies . eading pharmaceutical companies . provider technologies . Analyzed historical global health Goldman, Sachs & Co., New York, NY product launches for a philanthropic McKinsey & Company, London, UK Investment Banking Analyst & Associate, foundation . Developed manufacturing Analyst, 2015-2016 2013-2016 site investment strategy for a generic Specialized in the pharmaceuticals Advised natural resources companies pharmaceutical company . and medical products practice . Project through merger, acquisition, and capital highlights: (1) Worked with top-5 raising opportunities . Developed biopharma client to integrate out- expertise in precedent transaction, comes-based health business models discounted cash flow, LBO, and to improve market access (2) accretion / dilution analyses . Developed technology tool to assess client readiness for global biopharma launches; (3) Supported $20B company in commercial growth roadmap strategy in neurology .

27 Nina Underman David X. Wang Sarah R. Weber [email protected] [email protected] [email protected] Bowdoin College, Brunswick, ME Duke University, Durham, NC Williams College, Williamstown, MA B .A ., Neuroscience, 2015 B S. ., Summa Cum Laude, with Distinction, B .A ., Psychology & Neuroscience, 2011 Economics, 2014

An opportunity to work with a dynamic, An opportunity to identify, grow and Invest with integrity in the next mission-driven team to build and develop transform healthcare or technology generation of biopharma companies. healthcare delivery organizations. businesses through equity investing or business development roles. Nantahala Capital, New Canaan, CT OptumCare, Eden Prairie, MN Healthcare Equity Analyst, Summer 2019 Delivery Strategy Intern, Summer 2019 Cornell Capital, New York, NY Analyzed healthcare public equities Designed implementation plan on Private Equity MBA Intern, Summer 2019 for a long/short hedge fund . Focused behalf of care delivery organization Assessed control investments across primarily on biotech, including gene COO to improve primary care and healthcare, business and financial therapy, rare disease, oncology, and housing access for 225,000 Medicaid services, and consumer industries at microbiome . Performed due diligence patients . Developed payer, provider $3B AUM, cross-border U .S ./Asia fund . and valuation work on existing and local community partnering strat- Led diligence of professional employer investments and pitched new ideas egy needed to execute initiatives, organization and sourced 2 potential to the investment team . projected to reduce average care investment partners . costs 44% per member per month via Piper Jaffray & Co., New York, NY improved housing enrollment and home- MSD Partners, New York, NY Assistant Vice President, Sell-Side Equity less outreach processes, new tenancy Private Equity Associate, 2016-2018 Research, 2017-2018 support services and redesigned Evaluated control leveraged buyout Analyst, Sell-Side Equity Research, primary care models . Built data and structured investments for 2015-2017 infrastructure to enable ROI determi- Michael Dell’s $15B family office . Recommended 31 SMID cap biotech- nation for program investments . Invested in Ring Container (packaging) nology stocks . Built and updated and WCG (clinical trial services) . financial models, including valuation MaineHealth, Portland, ME Developed views on ~50 investments by DCF, NPV, comparable company System Development Manager, 2016-2018 across multiple industries, managed analysis . Analyzed business models System Development Business Analyst, deal and diligence workstreams, and market potential of pipeline 2015-2016 coordinated external advisors and assets, focusing on clinical diligence Led initiatives on behalf of EVP to built extensive 3-statement operating (physician surveys, physician calls, advance strategy and operations for models . Conducted outreach in pursuit medical conferences) to differentiate $3B, 10-hospital delivery system of annual investment themes and stock recommendations . serving 70% of Maine’s population, generated one-on-one meetings regularly collaborating with system with businesses . Marketing Evolution, New York, NY and hospital leadership . Implemented Senior Research Analyst, 2013-2014 operational benchmarking tool in 450 Morgan Stanley, New York, NY Research Analyst, 2013-2014 hospital and practice departments . Investment Banking Analyst, Healthcare, Analyzed success of direct-to-consumer Consulted with community hospital 2015-2016 pharma marketing campaigns and CFO to achieve $1 .6M budgeted Executed debt, equity, and M&A devised strategies to improve return savings via staffing model and supply transactions; counseled clients on on investment from pharma marketing chain redesigns . Supported General corporate strategy . Deals included spend . Counsel and Trustees in due diligence AmerisourceBergen’s acquisition of process for merger of 10 local PharMEDium from CD&R and Sagent Boston Children’s Hospital, Boston, MA members into single corporate entity . Pharmaceuticals’ sale to Nichi-Iko . Clinical Research Coordinator, 2011-2013 Managed all-payer claims database Oversaw operations of five clinical used guide COO’s system expansion Jefferies, New York, NY studies in Crohn’s Disease and efforts based on service leakage and Investment Banking Analyst, Healthcare, Ulcerative Colitis . Recruited patients growth analyses . 2014-2015 to trials, performed medical chart Advised clients on M&A and financing . reviews, collected biological samples, Deals included Seahorse Biosciences’ and analyzed data in SPSS . sale to Agilent and Pernix’s acquisition of Zohydro . .

28 Daichen Wei Richard E. Woo Schuyler D. Yost [email protected] [email protected] [email protected] University of California Berkeley, Berkeley, CA Rice University, Houston, TX Colgate University, Hamilton, NY B .A . Economics, 2012 B A. ., Mathematical Economic Analysis, 2013 B .A ., English, 2011

An opportunity to transform patient An opportunity to lead strategy at An opportunity to leverage technology care and to improve patient access a life sciences company in a business to improve the consumer experience in through commercialization of innovative development role or as an investor. health care. therapeutics. Gilead Sciences, Foster City, CA McKinsey & Company, Boston, MA The Janssen Pharmaceutical Companies Corporate Development Summer Associate, Summer Associate (People Analytics), of Johnson & Johnson, Horsham, PA Summer 2019 Summer 2019 Brand Marketing Summer Associate, Conducted in-depth diligence, market Assessed implications of major organi- Summer 2019 research and financial analyses for zational restructuring following a Developed personal and non-personal potential partnerships, licensing, acqui- healthcare services client’s acquisition now approved assets, including firsts sitions and investment opportunities . of a health insurance company . for immunology, to communicate Assisted in restructuring of European Translated a telecommunications approval of new indication at launch filgotinib commercial partnership as client’s future business priorities to across prioritized stakeholders; part of broader $5 5B. R&D collaboration talent needs and developed recom- Managed three internal and external with Galapagos . mendations to bridge emergent talent agencies and collaborated with six gap through hiring, acquihiring, and cross functional teams to incorporate Amgen, Thousand Oaks, CA upskilling existing employees . now approved campaign assets within Strategic Planning and Operations Manager, omni-channel tactical plan and launch 2017-2018 Centers for Medicare and Medicaid communication plan Gathered, analyzed and reported Services, Baltimore, MD organizational performance analytics Senior Advisor (CMMI), Summer 2018 KPMG, San Francisco, CA for the Devices and Final Drug Product Developed proactive talent acquisition Senior Associate 2014 – 2016 Technologies department . Managed strategy and built a performance Associate 2012 – 2014 resource forecasting and development management system for the Center Developed Medicaid pricing strategies timelines for drug delivery platforms for Medicare and Medicaid Innovation . for multi-billion dollar pharmaceutical across Amgen’s product portfolio . Recruited new Chief Medical Officer company during client and competitor and other key hires . product launches; pricing strategy HealthCor Partners Management, helped client secure approval and New York, NY Quartet Health, New York, NY maintain market share; Established Investment Associate, 2015-2017 Chief People Officer / Founding Team multi-billion dollar life sciences Sourced and evaluated new investment Member, 2015–2018 manufacturer’s operating procedure opportunities for $400M AUM late-stage Established and led the Human for compliance with National Physician venture healthcare fund across medical Resources and Recruiting functions for Payment Transparency Program by devices, biopharmaceuticals and digital the company . Led team of 6 to recruit analyzing millions of data points to health . Reviewed and evaluated and onboard 210 full-time employees . identify reportable transactions of company performance, provided Served as a member of the executive compensation to doctors/hospitals advice and built financial analyses team and presented to Board and to promote products for existing portfolio companies . Investors from Google Ventures and Oak HC/FT at quarterly Board J.P. Morgan, San Francisco, CA Meetings . Investment Banking Analyst, 2013-2015 Primary healthcare coverage analyst Oxeon Partners, New York, NY on 14 announced deals with a combined Co-Founder, Senior Associate, 2011-2015 transaction size of over $60B, including Partnered with Co-Founder / CEO to equity offerings, M&A advisory, con- define business model, values, and vertible debt offerings for biopharma- strategy . Built management teams ceutical and medical device companies . for leading healthcare technology Built discounted cash flow, leveraged and services companies . buyout, accretion/dilution, and tax inversion models .

29 2019 Internship Sponsors

The following organizations provided CITYBLOCK MAGENTA THERAPEUTICS internships for Health Care Management New York, NY Cambridge, MA Students in Summer, 2019. COMMODORE CAPITAL MANATT, PHELPS AND PHILLIPS New York, NY New York, NY

DAVITA MARSHALL WACE 4CATALZYER Denver, CO New York, NY Guilford, CT or New York, NY EDEN HEALTH MCKINSEY & COMPANY ACCENTURE STRATEGY New York, NY Jersey City, NJ New York, NY Charlotte, NC ELEANOR HEALTH Waltham, MA BAIN AND COMPANY Boston, MA Philadelphia, PA San Francisco, CA EVERCORE MILLIMAN HEALTHCARE BCG New York, NY Greater China Atlanta, GA Summit, NJ GATES FOUNDATION NANTAHALA CAPITAL MANAGEMENT Philadelphia, PA Seattle, WA Darien, CT

BLACKSTONE GENENTECH NEW MOUNTAIN CAPITAL New York, NY South San Francisco, CA New York, NY

BLUEBIRD BIO GILEAD NEWBROOK CAPITAL Boston, MA Foster City, CA New York, NY

BLUEPRINT MEDICINES GOLDMAN SACHS NOVARTIS PHARMACEUTICALS Cambridge, MA New York, NY East Hanover, NJ

BOSTON SCIENTIFIC GSK OLIVER WYMAN Maple Grove, MN Philadelphia, PA New York, NY

BUTTERNUT BOX HEALTH IQ PFIZER, INC. London, UK Mountain View, CA New York, NY

CAPITAL GROUP HUMANA PICNICHEALTH Los Angeles, CA Louisville, KY San Francisco, CA

CAREMORE INDIAN HEALTH SERVICES POST CAPITAL PARTNERS New York, NY Shiprock, NM New York, NY

CEDAR J.P. MORGAN QED THERAPEUTICS New York, NY New York, NY San Francisco, CA

CERNER CORPORATION JANSSEN PHARMACEUTICALS REGENERON PHARMACEUTICALS Kansas City, MI Philadelphia, PA Tarrytown, NY

CHC SOLUTIONS JOHNSON & JOHNSON SMILE CULTURE MANAGEMENT New York, NY San Francisco, CA Philadelphia, PA

CITADEL - SURVEYOR CAPITAL LLR PARTNERS SYNOVIUM New York, NY Philadelphia, PA Philadelphia, PA

30 TELADOC New York, NY

TRIALSPARK New York, NY UnitedHealth Group Eden Prairie, MN Minneapolis, MN

UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Philadelphia, PA

VARIAN MEDICAL San Francisco, CA

WALMART Bentonville, AR

WATERMARK New York, NY

ZENYTH PARTNERS Great Neck, NY

31 2019 Health Care Program Mentors

Mentors are leaders and senior managers GEOF BAKER DAVID S. BLOCK, M.D. in the health care field who have agreed CEO & Managing Director President VenAdvisory Gliknik Inc . to provide career and professional Seattle, WA Baltimore, MD development advice and guidance to VIKRAM BAKHRU, M.D. KARA BROTEMARKLE Health Care management students. Chief Operating Officer International Business Leader ConsejoSano, Inc . Roche / Genentech North Hollywood, CA Basel, Switzerland

NEIL E. BANSAL LUCAS BUCHANAN IMAN ABUZEID, M.D. Vice President of Business Development Chief Financial Officer CEO and Co-Founder Pharmscript Silk Road Medical Incredible Health, Inc . New York, NY Sunnyvale, CA San Francisco, CA ANDREW BARNELL ELENA CASTAÑEDA MATT ADKINS Chief Executive Officer Senior Director Director, Corporate Strategy Geneoscopy LLC Optum Humana St . Louis, MO New York, NY Louisville, KY SIMON BASSEYN, M.D. ELIZABETH CELATA ANIMESH AGARWAL Biotech Analyst Principal Sr . Manager Ghost Tree Capital The Boston Consulting Group Intrexon Corporation New York, NY Philadelphia, PA S . San Francisco, CA JAMIL M. BEG ALLI CHANDRA AMEYA AGGE Principal Senior Manager Managing Director 5AM Ventures AVIA BlueMountain Capital Boston, MA Chicago, IL New York, NY ALI BEHBAHANI, M.D. DUSTIN WM CHANG JESSICA AISENBREY General Partner Analyst Director, Performance Improvement New Enterprise Associates, Inc . Balyasny Assessment L P. . Boston Medical Center Chevy Chase, MD New York, NY Boston, MA ERIC BELL SARBANI CHAUDHURI DAVID ALLEN Managing Director Global Commercial Franchise Head: Director, Business Development and SpringRock Centures Neuromuscular Franchise, Licensing Seattle, WA Pfizer Rare Diseases Medtronic Pfizer Inc . Minneapolis, MN GRACE BELL New York, NY Director of Strategic Initiatives MARK ARPELS AMEZ-DROZ & Specialty Operations CHRISTOPHER P. CHEN Principal Associate, Corporate Development CareMore Health Medical Director Value Management, Medtronic Los Angeles, CA Associate Medical Director Hospitalists Minneapolis, MN UW Medicine, Valley Medical Center RYAN BERGER VICTORIA GOLDIN ATENCIO Seattle, WA Sr . Director of Product Development Marketing Director of Value Based Zynx Health, a division of Hearst GEORGE Z. CHEN, M.D. Partnerships Corporation SVP and Head of China Development Unit, Amgen Los Angeles, CA AstraZeneca Global Medicines Development Thousand Oaks, CA AstraZeneca ALEXIS BERNSTEIN KAREEN BACINSKI Shanghai, China Sr . Director, Client Services Director, Business Development Wellframe KELLY CHENG DePuy Synthes, Boston, MA Head of New Market Strategy a Johnson & Johnson Company Honor Flemington, NJ NIKHIL BHOJWANI San Francisco, CA Managing Partner DAVID BAIADA Recon Strategy MARK CHIN CEO Cambridge, MA Investment Director Bayada Home Health Care Arix Bioscience Moorestown, NJ DARREN M. BLACK New York, NY Managing Director Summit Partners L .P . Boston, MA

32 BRIAN G. CHOI, M.D. TANIA D. DIMITROVA DAN GEOFFRION Chief Medical Information Officer; Chief Business Officer Marketing Manager Professor of Medicine & Radiology Artios Medtronic The George Washington University New York, NY Minneapolis, MN Washington, DC AUSTIN DIXON, M.D. NAVID GHARAVI JIGAR CHOKSEY Fellow Physician, Department of Radiology Vice President Analyst Duke University Medical Center RLH Equity Highline Capital Durham, NC Los Angeles, CA New York, NY BENJAMIN DORANZ, PH.D. SEAN GLEESON, M.D. BRETT CHUNG President and CEO President Head of Product Integral Molecular, Inc . Partners For Kids, Nationwide Children’s RDMD Philadelphia, PA Hospital San Francisco, CA Columbus, OH CATHY DUREI EDDIE CISNEROS President/Founder JONATHAN GODIN, M.D. Executive Coach Rumbly Health Assistant Professor, Orthopaedic Surgery Inspirate Rye, NY Virginia Tech Carilion Clinic Schaumburg, IL Roanoke, VA TED EBEL RYAN COCHRAN Chief Business Officer NOAH GOODMAN Chief Financial Officer Colorescience, Inc . Director, Business Development One Homecare Solutions Carlsbad, CA Seres Therapeutics Miami, FL Cambridge, MA BRANDON EINSTEIN, M.D. SOLOMON COLE Vice President GARY L. GOTTLIEB, M.D. Vice President Enhanced Healthcare Partners Former Chief Executive Officer AB Private Credit Investors New York, NY Partners In Health (AllianceBernstein) Boston, MA Austin, TX RAMI ELGHANDOUR Former President and CEO VIKAS GOYAL DAVID COLLIER Nevro Principal CEO Redwood City, CA SR One Velocity Pharmaceutical Development Cambridge, MA And Presidio Partners MYRIAM EXUMÉ South San Francisco, CA Director, Regional Marketing TODD GUREN Merck Director TERI CONDON North Wales, PA Regence BlueCross BlueShield Vice President, Portland, OR Strategy and Business Development DANIEL FAGA QuantiaMD, a Sub of Physician’s Interactive Chief Business Officer LOVISA GUSTAFSSON Waltha, MA Spark Therapeutics Assistant VP Philadelphia, PA The Commonwealth Fund EMILIE COUEIGNOUX New York, NY Associate Director, Business Development JEFFREY FIORE Seattle Genetics Associate Director, Strategy PHILIP P. GUTRY Bothell, WA Teladoc Health Chief Business Officer New York, NY Kronos Bio MICHAEL CROMWELL San Mateo, CA VP of Strategic Development TOMMY FU, M.D. MDVIP Emergency Medicine Physician (JUSTIN) TAE JIN HAM Boca Raton, FL Lahey Hospital and Medical Center General Manager Burlington, MA Celgene (Korean Affiliate) KENNETH CUSTER Senior Director STEPHANIE GAMPPER JOHN HARRIS Portfolio Strategy and Decision Sciences Director Director Eli Lilly Cedars-Sinai Health System Veralon Zionsville, IN Beverly Hills, CA Philadelphia, PA

PITAMBER DEVGON, M.D. MRIDUL GANESH TODD HERRMANN Chief Medical Officer, Co-Founder Chief Product Officer President, Cadensuss Velano Vascular, Inc . Laudio Lecturer, Simmons School of Business Philadelphia, PA Cambridge, MA East Sandwich, MA

33 Health Care Program Mentors

JANE HERZECA ASH KHANNA JENNIFER LEE VP Operations Venture Partner Vice President Development Quartet Pivotal Bio Venture Partners Lyric Hospitality New York, NY San Francisco, CA San Francisco, CA

CARRIE HIEBELER MIKE KIJEWSKI RICHARD LEE, M.D. Senior Investment Officer CEO, Co-founder Associate Professor Ventas, Inc . MedCrypt Weill Cornell Medical College Winnetka, IL Solana Beach, CA New York, NY

ANNE HOANG JOYCE KIM ADAM LESSLER, M.D. Regional Senior Vice President, Operations, Director, Service Line Performance Principal The US Oncology Network Improvement and Data Analysis Canepa Healthcare McKesson Main Line Health New York, NY San Francisco, CA Newton Square, PA BRIAN LEWANDOWSKI SAM HOLLIDAY TINA KIND Analyst Co-Founder & COO Managing Partner Tamarack Capital Management HEROIQ Health DTS Group Carlsbad, CA New York, NY Orlando, FL CHRISTINA LIAO BRIAN HOLZER, M.D. ERIC KLEIN Senior Consultant, Clinical/Transformation CEO Vice President Cedars-Sinai Health System Lacuna Health, A Kindred Healthcare Bridge Growth Partners Santa Monica, CA Company New York, NY Louisville, KY YI LIAO CLAYTON D. KNOX, M.D. Senior Product Manager YANG HU Chief Operating Officer Vidyo, Inc . Global Health Fellow MavuPharma Sioux Falls, SD Bill & Melinda Gates Foundation Kirkland, WA Seattle, WA JEFFREY S. LITWIN, M.D. MICHAEL KOBY Chief Operating Officer, BOB HUANG Partner Clinical Services Organization Investment Director 1315 Capital WCG Clinical Seidler Equity Australia Philadelphia, PA Princeton, NJ Sydney, NSW, Australia DAVE KONCIAK GABRIEL LUFT BRANDON HULL VP, Business Development & Strategy Vice President Cardinal Partners (Retired Member) Surface Oncology Amulet Capital Partners New Mountain Capital (Industry Advisor) Cambridge, MA Greenwich, CT Norfolk, VA AARON KORNETZKE RENZO LUZZATTI OREN K. ISACOFF Business Development President Principal Doximity US - Rx Care Longitude Capital San Francisco, CA Vienna, VA Greenwich, CT SRI KOTTE SARAH LYON VIVEK JAIN Head of Partnerships Director, Medtronic Vascular Strategy Vice President Genome Medical & Portfolio Management H .I .G . Capital S . South Francisco, CA Medtronic New York, NY Plymouth, MN MICHAEL KRAMARZ EMILY JANVEY, M.D. Investment Research Analyst JOSH MAGID Director Samlyn Capital, LLC Associate, Healthcare KKR New York, NY Evercore Menlo Park, CA New York, NY LISA A. LACASSE MAGGIE (HILL) JARRETT Deputy President & SVP, JOAN MAGRUDER Principal Strategy & Operations President, St . Louis Children’s Hospital; Cedar Investors American Cancer Society Group President, BJC HealthCare Denver, CO Cancer Action Network St . Louis Children’s Hospital Washington, DC St . Louis, MO PRASHANTH JAYARAM, M.D. Portfolio Manager DAVID LAMACCHIA SAMIR MALIK Citadel Global Equities Principal Founder / General Manager New York, NY NaviMed Capital Genoa Telepsychiatry (United Health Group) Milton, GA New York, NY TYLER JORGENSEN Consultant ELAINE LE GREGG MCCONNELL BCG Corporate Development Associate VP Boston, MA Medtronic Blue Rock Therapeutics Shanghai, China Washington, DC KEVIN JURKOWSKI Director, Program Management Abbott Sylmar, CA

34 ROBERT C. MCDONALD, M.D. YELENA OFENGEYM ALEX ROSEN President Manager Investor Aledo Consulting, Inc . Manatt Health Strategies Venrock Indianapolis, IN New York, NY New York, NY

KAREN MEADOR, MD JUSTIN PALLARI CRAIG E. SAMITT, M.D. Senior Physician Executive, Director President & CEO Managing Director Clinton Health Access Initiative Blue Cross Blue Shield of Minnesota BDO New Delhi, India Eagan, MN New York, NY SHAUNAK PARIKH MATT SCHULZ JEAN M. MELLETT Principal Vice President Associate Vice President, EW Healthcare Partners The Vistria Group Planning & Strategy New York, NY Chicago, IL Northern Light Health Brewer, ME JEAN PATTERSON DAVID M. SCHUPPAN Senior Vice President Partner MICHAEL C. MENG AoN The Vistria Group Chairman, President & CFO Boston, MA Chicago, IL Stellar Health New York, NY CARY PFEFFER, M.D. JOHN SCHWARZ Partner Vice President, Administration GREG MILLHAUSER Third Rock Ventures Lankenau Medical Center Portfolio Manager of Private Investments Boston, MA Main Line Health The Glenmede Trust Wynnewood, PA Philadelphia, PA GARY M. PHILLIPS, M.D. President & Chief Executive Officer REBECCA SCHWIETZ GRETCHEN MILLS OrphoMed, Inc . Senior Vice President, Clinical Services Manager Strategy and Market Research Blue Bell, PA Healthfirst 3M Health Information Systems New York, NY Murray, UT MATTHEW PICKENS President, West Region ANKIT SHAH SACHIYO MINEGISHI Press Ganey Senior Director, Commercialization VP, Lead for Sickle Cell Disease Program Palmetto Bay, FL SeltPoint Medical bluebird bio Valencia, CA Cambridge, MA SALLY POBLETE Founder and CEO DEEPA D. SHAH MATT MOURADIAN Wellthie Senior Director, Growth Chief Operating Officer New York, NY Landmark Health Renew .com Hermosa Beach, CA Santa Monica, CA DARSHAN PRABHU Managing Director RAVI N. SHAH, M.D. DAN MULREANY Starr Investment Holdings Medical Director Associate Director, New York, NY Columbia Psychiatry Business Development Faculty Practice Organization QED Therapeutics JON MICHAEL REESE New York, NY Sand Francisco, CA Vice President General Atlantic DAVID SHEEHY HAREESH NAIR New York, NY COO Managing Director Sage Growth Partners, LLC Fosun Healthcare Holdings BOWIE REMALEY Baltimore, MD Singapore Vice-President, Operations Radiology Partners ANDREW SHELTON DAVID B. NASH, M.D. El Segundo, CA Director, Growth Strategy Dean-College of Population Health Premise Health Jefferson College of Population Health JAMES RHODES Brentwood, TN Philadelphia, PA Vice President, Strategy and Business Development ED SHENKAN NAOKO NISHITANI Children’s Health System of Texas CEO Associate Partner Dallas, TX Shenkan Advisors ZS San Francisco, CA Princeton, NJ JAMES (JAMIE) RICHTER VP, Business Development DAVID SILK MATT NIX ReMed Global Marketing Lead, Senior Mgr . Solution Engineering Paoli, PA Healthcare and Life Sciences, Instamed Google Cloud Philadelphia, PA PAMELA RODMAN Google Director, Finance and Administration New York, NY WESLEY NURSS Columbia University Portfolio Analyst New York, NY DANIEL SIMON Marshall Wace SVP, BioPharma Business New York, NY BEN ROOKS Guardant Health Managing Director Redwood City, CA ST Advisors, Inc . San Francisco, CA

35 Health Care Program Mentors

BETH SOMERS STUTZMAN JONATHAN WANG Principal and Career coach SVP & Head of Somers Stutzman Consulting Business Development Lexington, MA Zai Lab Shanghai, China MAUREEN A. SPIVACK Senior Healthcare Industry Partner CHRIS WILKERSON New State Capital Partners President Larchmont, NY EquipSystems, LLC New York, NY JAMES STANFORD Co-Founder, Managing Partner HELENE WOLK Fitzroy Health Holdings, LLC SVP Operations/COO New York, NY Englewood Health Englewood, NJ CHARLES “SCOTLAND” STEVENS General Partner CHIA WU, M.D. OrbiMed Advisors LLC Orthopaedic Hand Surgeon New York, NY New York Presbyterian -- Columbia University WILL STRATTON New York, NY Manager, Corporate and Global Business Development AMANDA WYATT Rakuten Aspyrian Marketing Manager San Diego, CA Pfizer Inc . New York, NY MICHAEL STROUP SVP Acquisitions YAN YAN, M.D. United Surgical Partners International Senior Director, Corporate Strategy Dallas, TX Quest Diagnostics Secaucus, NJ FERNANDO TORRES Vice President MO YANG Kaufman Hall Vice President Atlanta, GA GI Partners San Francisco, CA GEOFFREY TRESLEY Vice President JON YEATMAN GTCR Chief Strategy Officer Chicago, IL Mission Health Asheville, NC MAYA TSUKERNIK VP, Customer Innovation DANIEL YIP Aetion, Inc . VP, Commercial Operations New York, NY Intercept Pharmaceuticals New York, NY JOHN URQUHART Partner BRANDI (HERMAN) YODER HealthCare Royalty Partners Sr . Finance Director Boston, MA Johnson & Johnson (Ethicon) Cincinnati, OH DANIEL VAN DEN BERGH Investor DEREK YUAN Kaiser Permanente Ventures Senior Director, Corporate Development Oakland, CA Zai Lab Shanghai, China REED VAN GORDEN Managing Director THOMAS ZIPP Deerpath Capital Management Head of Strategy & Brand Development Chicago, IL Vygen Exton, PA JEFF VOIGT Principal Medical Device Consultants of Ridgewood LLC Ridgewood, NJ

DAVE WALTON CEO and Founder Chronicare Newtown, PA

36 Administration

GEOFFREY M. GARRETT, PH.D. Dean, The Wharton School

HOWARD KAUFOLD, PH.D. Vice Dean and Director, The Wharton Graduate Division

SCOTT E. HARRINGTON, PH.D. Chair, Health Care Management Department, The Wharton School; Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A. Associate Director, MBA Program in Health Care Management

CAROLINE SAVOIE Administrative Coordinator, MBA Program in Health Care Management

JANICE SINGLETON Administrative Coordinator, MBA Program in Health Care Management

37 Faculty

The Program Faculty are drawn from EZEKIEL J. EMANUEL, M.D., PH.D. JUNE M. KINNEY, M.A. the Wharton School, the School of Diane v .S . Levy and Robert M . Associate Director, Graduate Program Levy University Professor and in Health Care Management; Medicine, the School of Nursing, and Vice Provost for Global Initiatives; Lecturer, Health Care Management, the School of Arts and Sciences at the Professor, Health Care Management, The Wharton School University of Pennsylvania and leading The Wharton School GARY J. KURTZMAN, M.D. health institutions in Philadelphia. BRADLEY M. FLUEGEL Vice President, Life Sciences, Additional support is provided by the Senior VP & Chief Strategy Safeguard Scientifics; Lecturer, Officer, Walgreens; Health Care Management, Fellows and Associates of the Leonard Lecturer, Health Care Management, The Wharton School Davis Institute of Health Economics. The Wharton School RISA LAVIZZO-MOUREY, M.D., M.B.A THOMAS N. GILMORE, M.ARCH. PIK Professor of Population Health Vice President, and Health Equity The Center for Applied Research Inc .; Perelman School of Medicine, School ABBY E. ALPERT, PH.D. Senior Fellow, Health Care Management, of Nursing and The Wharton School Assistant Professor, The Wharton School University of Pennsylvania Health Care Management, The Wharton School JOHN P. GLASER, PH.D. CLAUDIO LUCARELLI, PH.D. Senior Vice President, Client Associate Professor, EUGENIO ANESSI, PH.D. Administration, Cerner Corporation; Health Care Management, Professor, Public Management, Lecturer, Health Care Management The Wharton School Bocconi University Graduate School The Wharton School of Management, Milan, Italy; JEFFREY P. LIBSON, J.D. Lecturer and Senior Fellow, HENRY A. GLICK, PH.D. Partner, Cooley; Health Care Management, Professor of Medicine, Lecturer, Health Care Management, The Wharton School Perelman School of Medicine at The Wharton School the University of Pennsylvania; HARI MAHADEVAN, PH.D. DAVID A. ASCH, M.D., M.B.A. Professor, Health Care Management, Independent Consultant; Executive Director, The Wharton School Penn Medicine Center for Health Lecturer and Senior Fellow, Care Innovation; MATTHEW R. GRENNAN, PH.D. Health Care Management, Professor of Medicine, Assistant Professor, The Wharton School Perelman School of Medicine Health Care Management, INGRID NEMBHARD, PH.D., M.S. at the University of Pennsylvania; The Wharton School Professor, Health Care Management, Fishman Family President’s The Wharton School ATUL GUPTA, PH.D. Distinguished Associate Professor, Assistant Professor, Health Care Management, THOMAS E. BAKER, J.D. Health Care Management, The Wharton School William Maul Measey Professor of The Wharton School Law and Health Sciences, University STEVEN A. NICHTBERGER, M.D. of Pennsylvania Law School; SCOTT E. HARRINGTON, PH.D. Adjunct Professor and Senior Fellow, Professor of Health Care Management, Chair, Health Care Management Health Care Management, The Wharton School Department, and Director, The Wharton School Health Care Management Program, MITESH S. PATEL, M.D. LAWTON R. BURNS, PH.D., M.B.A. The Wharton School Assistant Professor of Medicine, Perelman James Joo-Jin Kim Professor of Health Alan B . Miller Professor of Health Care School of Medicine at the University Care Management, The Wharton School; Management and Business Economics of Pennsylvania School of Medicine; Faculty Co-Director, and Public Policy, The Wharton School Roy and Diana Vagelos Program Assistant Professor of Health Care In Life Sciences & Management ERIC M. HEIL Management, The Wharton School SVP, Chief Commercial Officer MARK V. PAULY, PH.D. PATRICIA M. DANZON, PH.D. Software Solutions, NaviHealth, Inc .; John M . and Thomas L . Bendheim Celia Z . Moh Professor Emeritus Lecturer, Health Care Management, Professor; Professor, Health Care of Health Care Management, The Wharton School Management, Business Economics and The Wharton School Public Policy, The Wharton School; JOHN C. HERSHEY, PH.D. Professor, Economics, College of Arts GUY DAVID, PH.D. Anheuser-Busch Professor Emeritus and Sciences Gilbert and Shelley Harrison of Management Science; and Associate Professor, Health Care Management, WILLIAM P. PIERSKALLA, PH.D. Health Care Management, The Wharton School Professor Emeritus The Wharton School JOHN KIMBERLY, PH.D. BENJAMIN DORANZ, PH.D., M.B.A. Henry Bower Professor Emeritus, Health President and CEO, Integral Molecular Care Management, The Wharton School Senior Fellow, Health Care Management, The Wharton School

38 DANIEL POLSKY, PH.D. RACHEL M. WERNER, M.D., PH.D Robert D. Eilers Professor of Health Care Associate Professor of Medicine, Management and Economics, Perelman School of Medicine at the The Wharton School; University of Pennsylvania School of Professor of Medicine, Medicine; Associate Professor and Senior Perelman School of Medicine Fellow, Operations and Information at the University of Pennsylvania; Management, Health Care Management, Executive Director, Leonard Davis The Wharton School Institute of Health Economics JOHN J. WHITMAN, M.B.A. DOUGLAS A. PRESENT, M.B.A. Executive Director, The TRECS Institute; Investor and Advisor; Lecturer, Health Care Management, Lecturer, Health Care Management, The Wharton School The Wharton School SANKEY V. WILLIAMS, M.D. ARNOLD J. ROSOFF, J.D. Professor of General Professor Emeritus, Internal Medicine; Professor, Legal Studies and Business Ethics; Health Care Management, Lecturer, Health Care Management, The Wharton School The Wharton School

STEPHEN M. SAMMUT Lecturer and Senior Fellow, Health Care Management, Lecturer, Entrepreneurial Programs, The Wharton School

CYNTHIA SCALZI, M.N., PH.D. Professor Emeritus of Nursing and Health Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal The University of Pennsylvania Medicine, Perelman School of Medicine values diversity and seeks talented at the University of Pennsylvania; students, faculty and staff from diverse Professor, Health Care Management, backgrounds. The University of The Wharton School Pennsylvania does not discriminate on the basis of race, sex, sexual JEFFREY H. SILBER, M.D., PH.D. orientation, gender identity, religion, Director, Center for Outcomes Research, color, national or ethnic origin, age, The Children’s Hospital of Philadelphia; JUNE KINNEY disability, or status as a Vietnam Era Professor of Pediatrics and Associate Director, MBA Program Veteran or disabled veteran in the Anesthesiology & Critical Care, in Health Care Management administration of educational policies, Perelman School of Medicine at The Wharton School programs or activities; admissions the University of Pennsylvania; policies; scholarship and loan awards; Professor, Health Care Management, athletic, or other University adminis- The Wharton School tered programs or employment. JEFFREY A. SOLOMON, M.D., M.B.A. Questions or complaints regarding Founding Partner, Infiniti Medical LLC; this policy should be directed to: Lecturer, Health Care Management, Executive Director, The Wharton School Office of Affirmative Action ASHLEY SWANSON, PH.D. and Equal Opportunity Programs Sansom Place East Assistant Professor, 3600 Chestnut Street, Suite 228 Health Care Management, Philadelphia, PA 19104-6106 The Wharton School 215.898.6993 (Voice) KEVIN G.M. VOLPP, M.D., PH.D. 215.898.7803 (TDD) Director, Center for Health Incentives and Behavioral Economics, ©2019, The Trustees of Leonard Davis Institute; the University of Pennsylvania. Professor of Medicine, All rights reserved. Perelman School of Medicine at the University of Pennsylvania; SCOTT E. HARRINGTON, PH.D. Professor, Health Care Management, Director, The Wharton School MBA Program in Health Care Management, Photography of students: adamgierkephotography.com The Wharton School

39 Wharton The Wharton School University of Pennsylvania

MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218

215 .898 .6861 https://hcmg .wharton .upenn .edu